Other and unspecified disorders of skin and subcutaneous tissue

L12_SKINSUBCUTISNAS

skin disease: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L98.80, L98.88, L98.9 Hospital discharge: ICD-9 — 7019X\|7098\|7099 Hospital discharge: ICD-8 — 70198\|7090[8-9] Hospital discharge: excluded ICD-9 — 7098A\|7098B Cause of death: ICD-10 — L98.80, L98.88, L98.9 Cause of death: ICD-9 — 7019X\|7098\|7099 Cause of death: ICD-8 — 70198\|7090[8-9] Cause of death: excluded ICD-9 — 7098A\|7098B 2 out of 7 registries used, show all original rules.	2519
4. Check minimum number of events None	2519
5. Include endpoints None	2519
6. Filter based on genotype QC (FinnGen only)	2519

Control definitions (FinnGen only)

Control exclude: L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	L12_SKINSUBCUTISNAS
CONTROL_EXCLUDE	L12_OTHERSKINSUBCUTIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L98[8-9]
HD_ICD_9	7019X\|7098\|7099
HD_ICD_8	70198\|7090[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	7098A\|7098B
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L98[8-9]
COD_ICD_9	7019X\|7098\|7099
COD_ICD_8	70198\|7090[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	7098A\|7098B
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified disorders of skin and subcutaneous tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	14996	8917	5967
Only index persons	12956	7849	5107
Unadjusted period prevalence (%)
Whole population	0.22	0.26	0.17
Only index persons	0.25	0.29	0.19
Median age at first event (years)
Whole population	51.34	52.02	50.23
Only index persons	49.71	50.36	48.71

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2519	1570	949
Unadjusted period prevalence (%)	0.49	0.54	0.42
Median age at first event (years)	53.97	51.84	57.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2337: Matched controls
23370

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6431.5

323.0

1840

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.6

220.4

571

948

L98.88

ICD-10 Finland

Other specified disorders of skin and subcutaneous tissue

120.9

176.1

189

70908

ICD-8 Finland

Other diseases of skin, Alii definiti

+∞

123.0

117

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

111.2

1266

7135

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.3

95.3

396

1062

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.8

93.6

748

3313

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

92.7

482

1571

E000001

ATC

2.9

89.8

668

2811

E0000UV

ATC

2.5

88.5

1101

6224

TQW99

NOMESCO Finland

Other minor procedure on skin

5.8

87.1

264

501

XQ802

NOMESCO Finland

Epicutan test

6.4

83.7

233

396

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.4

80.4

316

795

XQ800

NOMESCO Finland

Prick test

4.4

78.8

314

800

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.5

78.7

303

746

70909

ICD-8 Finland

Other diseases of skin, Unspecified

+∞

77.5

D07AC01

ATC

betamethasone; topical

2.2

66.8

910

5162

H25.8

ICD-10 Finland

Other senile cataract

3.2

66.3

388

1353

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.7

65.6

532

2296

H02AB04

ATC

methylprednisolone; systemic

2.8

65.3

486

1991

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

5.0

65.3

223

481

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

14.8

64.0

109

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

63.7

470

1911

D07AC13

ATC

mometasone; topical

2.3

62.4

789

4287

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

33.5

61.8

J01MA12

ATC

levofloxacin; systemic

2.6

61.6

549

2489

J01FF01

ATC

clindamycin; systemic

2.3

61.3

740

3926

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

60.8

615

2987

D07AD01

ATC

clobetasol; topical

2.7

59.9

463

1928

SPAT1263

SPAT

Sampling

2.1

59.4

1118

7191

H02AB06

ATC

prednisolone; systemic

2.0

58.7

1190

7873

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.5

57.9

525

2393

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

57.4

1033

6491

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

55.7

895

5345

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.8

55.6

407

1634

L57.0

ICD-10 Finland

Actinic keratosis

3.2

55.4

322

1108

XG410

NOMESCO Finland

Flow-volume spirometry

4.9

54.6

188

408

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.7

52.9

248

721

SPAT1216

SPAT

Assessment of functional ability

2.5

52.5

474

2140

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

50.2

766

4430

SPAT1153

SPAT

Removal of sutures

2.0

49.8

843

5085

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

48.8

392

1653

NF1AA

NOMESCO Finland

Hip X-ray examination

3.1

48.1

296

1054

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

47.3

774

4580

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

47.3

313

1168

SPAT1254

SPAT

Administration of medicine

2.5

47.1

433

1965

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

45.9

408

1816

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.4

45.5

142

275

S18

ICPC

Laceration/cut

1.9

45.1

1029

6871

SPAT1211

SPAT

Application of soft bandage

3.0

45.0

293

1082

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.7

44.7

117

181

H02AB07

ATC

prednisone; oral

2.4

44.5

418

1912

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

3.5

43.9

218

662

L04AA06

ATC

mycophenolic acid; systemic

9.3

43.8

104

SPAT1310

SPAT

Counselling related to known health issue

1.9

43.6

817

5061

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

5.8

42.6

125

225

7099X

ICD-9 Finland

Other disorders of skin and subcutaneous tissue, Unspecified disorder of skin and subcutaneous tissue

+∞

40.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.5

40.7

345

1489

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

40.3

425

2053

7098X

ICD-9 Finland

Other disorders of skin and subcutaneous tissue, Other specified disorders of skin[MORBI CUTIS ET SUBCUTIS ALIA DEFINITA]

+∞

39.7

C03CA01

ATC

furosemide; systemic

2.0

39.7

686

4091

AA1AD

NOMESCO Finland

CT of head and brain

2.0

39.3

612

3502

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

4.8

39.1

135

293

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

38.9

359

1617

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

38.8

458

2328

127

Kela drug reimbursment

Transplant complication

9.0

38.1

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.4

37.9

197

618

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.4

37.9

143

340

WQ021

NOMESCO Finland

40.0

37.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

37.3

1008

6976

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.6

36.8

133

303

Z00.0

ICD-10 Finland

General medical examination

2.1

36.5

488

2612

Z04.3

ICD-10 Finland

Examination and observation following other accident

6.0

35.5

101

175

J01DB01

ATC

cefalexin; oral

1.9

35.1

1879

15974

Z01.2

ICD-10 Finland

Dental examination

1.8

34.6

963

6673

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

4.3

34.5

133

323

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.2

34.4

136

338

S97

ICPC

Chronic ulcer skin

3.8

34.4

151

413

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

34.3

297

1289

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.0

34.3

217

782

D02AE01

ATC

carbamide; topical

3.1

34.3

205

710

N03AX16

ATC

pregabalin; oral

1.9

34.2

573

3344

A02BC02

ATC

pantoprazole; systemic

1.7

33.2

1503

11972

Z94.0

ICD-10 Finland

Kidney transplant status

12.0

33.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.4

31.8

136

L04AX01

ATC

azathioprine; systemic

3.8

31.6

142

396

UKC02

NOMESCO Finland

Cystoscopy

2.1

31.4

396

2052

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.5

31.3

156

473

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

31.3

1151

8573

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.6

30.7

145

422

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

30.6

271

1186

N02AX02

ATC

tramadol; systemic, rectal

1.7

30.5

961

6832

ZXC50

NOMESCO Finland

Cryotherapy

4.7

30.3

106

234

L04AA01

ATC

[U] ciclosporin; systemic

8.0

30.2

R06AE07

ATC

cetirizine; oral

1.7

29.8

994

7166

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

29.8

161

519

NG2AA

NOMESCO Finland

Patella X-ray examination

4.5

29.8

108

247

QBJ30

NOMESCO Finland

Correction of abdominal apron

14.6

29.7

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

5.6

29.7

165

L04AD01

ATC

ciclosporin; systemic

6.5

29.2

121

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

29.2

297

1393

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

29.0

524

3114

D82

ICPC

Teeth/gum disease

1.7

28.9

781

5289

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.2

28.8

163

542

L93.0

ICD-10 Finland

Discoid lupus erythematosus

151.9

28.7

M05BA04

ATC

alendronic acid; oral

2.5

28.7

234

980

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.5

28.6

237

1002

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

11.3

28.1

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

28.0

770

5227

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.2

27.8

298

1432

N02AA05

ATC

oxycodone; systemic

2.1

27.7

355

1846

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.8

27.5

189

714

L89

ICD-10 Finland

Decubitus ulcer and pressure area

19.8

27.4

R23.8

ICD-10 Finland

Other and unspecified skin changes

2.0

27.3

383

2065

A46

ICD-10 Finland

Erysipelas

2.1

27.0

327

1657

L28

ICPC

Limited function/disability (L)

2.0

27.0

390

2127

SPAT1172

SPAT

Guidance concerning hydration

4.8

27.0

198

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

26.9

237

1033

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

4.4

26.9

100

235

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.5

26.7

218

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.6

26.7

200

798

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.5

26.6

110

SPAT1312

SPAT

General health counselling

1.7

26.6

750

5109

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

26.6

261

1200

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

26.5

642

4179

M01AE02

ATC

naproxen; oral, rectal

1.6

26.5

1281

10075

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

26.3

160

558

WX722

NOMESCO Finland

PEEP

3.2

26.1

147

486

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.5

25.8

223

962

N02BE01

ATC

paracetamol; systemic, rectal

1.8

25.7

1964

17406

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

5.1

25.7

164

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

25.7

203

834

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.6

25.6

140

70198

ICD-8 Finland

Other hypertrophic and atrophic conditions of the skin, Alii definiti

+∞

25.0

SPAT1262

SPAT

Handing over of treatment supplies

1.9

24.8

436

2552

D07CC01

ATC

betamethasone and antibiotics; topical

2.1

24.7

315

1628

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

12.1

24.7

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

4.1

24.7

245

WQ007

NOMESCO Finland

27.9

24.5

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

24.4

221

973

137

Kela drug reimbursment

Uraemia requiring dialysis

11.1

24.4

J01DA01

ATC

[U] cefalexin; systemic

1.6

24.3

1411

11493

TQW80

NOMESCO Finland

Local dermatologic skincare

4.7

24.3

184

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

4.1

24.2

240

JN4AD

NOMESCO Finland

Body CT examination

2.5

24.1

200

843

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

24.1

153

550

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.1

24.1

138

464

L03

ICPC

Low back symptom/complaint

1.7

24.0

557

3562

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.6

24.0

184

744

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

23.8

255

1223

D07AB08

ATC

desonide; topical

2.2

23.6

255

1225

ZZA00

NOMESCO Finland

Split skin graft

4.4

23.5

204

V03AE01

ATC

polystyrene sulfonate; oral

7.2

23.4

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

16.3

23.2

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

7.4

23.0

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

4.2

22.9

214

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.5

22.9

183

757

R06.0

ICD-10 Finland

Dyspnoea

1.7

22.7

547

3528

J02AC01

ATC

fluconazole; systemic

1.6

22.7

881

6468

PC6DE

NOMESCO Finland

232.2

22.7

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

22.4

168

670

G47.3

ICD-10 Finland

Sleep apnoea

1.8

22.2

455

2788

XF640

NOMESCO Finland

3.8

22.2

255

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.6

22.2

N06AA09

ATC

amitriptyline; systemic

2.2

22.2

253

1246

SPAT1229

SPAT

Assessment of need for aid

2.3

22.1

215

983

SPAT1234

SPAT

Support of social functional capacity

2.8

22.1

146

539

A02BC05

ATC

esomeprazole; systemic

1.6

22.0

914

6808

P01BA02

ATC

hydroxychloroquine; oral

2.3

21.9

218

1007

TGC00

NOMESCO Finland

Bronchial lavation

4.1

21.9

214

L82

ICD-10 Finland

Seborrhoeic keratosis

2.0

21.9

323

1767

A12AA04

ATC

calcium carbonate; oral

6.1

21.7

B07.9

ICD-10 Finland

Verruca simplex

3.8

21.6

256

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.3

21.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.7

21.4

151

582

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.7

21.2

260

D07BC01

ATC

betamethasone and antiseptics; topical

2.0

21.2

281

1472

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

21.0

232

L13

ICPC

Hip symptom/complaint

1.8

21.0

383

2256

J01MA02

ATC

ciprofloxacin; systemic

1.6

21.0

853

6301

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.7

21.0

258

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

20.9

642

4418

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

19.6

20.8

V03AE02

ATC

sevelamer; oral

15.0

20.7

J01MA01

ATC

ofloxacin; systemic

2.2

20.6

221

1054

Z49.0

ICD-10 Finland

Preparatory care for dialysis

9.5

20.6

D06BB10

ATC

imiquimod; topical

2.9

20.5

132

478

L30.3

ICD-10 Finland

Infective dermatitis

3.5

20.5

284

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.9

20.5

132

479

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.4

20.4

118

L91.0

ICD-10 Finland

Hypertrophic scar

25.7

20.4

R50.9

ICD-10 Finland

Fever, unspecified

1.9

20.4

315

1747

M79.1

ICD-10 Finland

Myalgia

2.0

20.3

301

1646

WX202

NOMESCO Finland

Supraclavicular plexus blockade

5.7

20.3

103

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

20.2

908

6850

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

20.1

769

5581

L50.8

ICD-10 Finland

Other urticaria

5.2

20.0

125

K03.66

ICD-10 Finland

Tooth plaque

2.4

20.0

171

732

TQW40

NOMESCO Finland

Remowal of suture of skin

2.4

20.0

179

783

B05DA

ATC

Isotonic solutions

11.4

19.9

N05BA04

ATC

oxazepam; oral

1.7

19.9

542

3604

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

19.9

509

3325

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

8.9

19.9

7019X

ICD-9 Finland

Other hypertrophic and atrophic conditions of skin, Unspecified hypertrophic and atrophic conditions of skin[HYPERTROPHIA SEU ATROPHIA CUTIS NUD]

+∞

19.8

SPAT1104

SPAT

Monitoring of emergency patient

2.3

19.8

187

843

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.7

19.8

250

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

19.7

217

1049

J01AA04

ATC

lymecycline; systemic

1.9

19.7

295

1619

L17

ICPC

Foot/toe symptom/complaint

1.6

19.6

553

3710

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.1

19.5

111

372

A07AA02

ATC

nystatin; oral

2.5

19.4

159

667

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.8

19.4

219

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

13.4

19.2

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

19.2

592

4065

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.7

19.0

136

528

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.6

18.9

100

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

9.2

18.9

R01AD08

ATC

fluticasone; nasal

1.6

18.8

623

4352

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.1

18.8

224

1121

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

18.8

199

945

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

18.7

1160

9338

D07CB01

ATC

triamcinolone and antibiotics; topical

4.1

18.6

187

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.8

18.5

213

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.6

18.4

503

3339

D07XC01

ATC

betamethasone, combinations; topical

1.9

18.3

275

1508

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

30.3

18.3

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

18.3

181

834

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

9.0

18.1

M04AA01

ATC

allopurinol; systemic

1.9

18.1

273

1498

R32

ICD-10 Finland

Unspecified urinary incontinence

3.3

18.1

291

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

2.1

18.1

227

1160

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

3.2

18.0

303

WQ020

NOMESCO Finland

33.2

18.0

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

17.9

228

1171

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

17.9

125

477

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

11.1

17.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

3.4

17.7

269

WZC30

NOMESCO Finland

Teaching

1.8

17.6

304

1752

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.1

17.6

207

1029

E000006

ATC

2.2

17.6

179

834

CS494

NOMESCO Finland

Other visual field testing

3.8

17.6

207

I78.1

ICD-10 Finland

Naevus, non-neoplastic

3.7

17.3

215

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

24.2

17.3

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

17.3

240

1278

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

42.3

17.3

S77

ICPC

Malignant neoplasm of skin

5.6

17.2

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.1

17.2

308

DFF00

NOMESCO Finland

Pure tone audiometry

2.0

17.1

218

1121

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

16.9

828

6296

A11CC03

ATC

alfacalcidol; systemic

4.0

16.8

175

FN1AD

NOMESCO Finland

CT of coronary arteries

5.0

16.7

107

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.5

16.7

H26.3

ICD-10 Finland

Drug-induced cataract

9.8

16.6

M02AA10

ATC

ketoprofen; topical

1.7

16.6

359

2224

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.9

16.5

113

E0001A1

ATC

4.0

16.4

169

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

16.4

458

3047

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

16.4

142

613

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

16.3

185

908

R4110

NOMESCO Finland

Physiotherapy

0.6

16.2

248

3982

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.6

16.2

124

X58

ICD-10 Finland

Exposure to other specified factors

1.8

16.1

291

1700

L92.0

ICD-10 Finland

Granuloma annulare

47.8

16.0

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

47.8

16.0

SPAT1301

SPAT

No procedures

1.5

16.0

682

5017

NF1DA

NOMESCO Finland

X-ray of hips

3.7

15.9

189

B05DB

ATC

Hypertonic solutions

10.1

15.9

J01CA04

ATC

amoxicillin; systemic

1.5

15.9

1758

15650

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.8

15.9

275

1583

J05AB01

ATC

aciclovir; systemic

1.6

15.9

464

3116

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

15.9

854

6595

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

15.9

219

1163

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

15.8

174

841

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

15.8

242

1336

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.5

15.8

763

5763

WX110

NOMESCO Finland

Local anesthesy

1.4

15.8

1447

12396

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

15.7

316

1912

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

8.8

15.7

NHQ40

NOMESCO Finland

Amputation of toe

6.5

15.7

R60.0

ICD-10 Finland

Localized oedema

1.9

15.6

244

1356

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.8

15.6

104

388

L16

ICPC

Ankle symptom/complaint

1.9

15.5

234

1285

N18.0

ICD-10 Finland

End-stage renal disease

6.4

15.5

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.8

15.5

108

S29

ICPC

Skin symptom/complaint other

1.7

15.4

367

2329

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

15.4

512

3551

TK800

NOMESCO Finland

Hemodialysis

4.1

15.4

145

J02AC02

ATC

itraconazole; systemic

1.7

15.4

394

2554

M25.5

ICD-10 Finland

Pain in joint

1.5

15.2

593

4265

D05BB02

ATC

acitretin; oral

3.6

15.2

192

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

3.6

15.1

193

K02.1

ICD-10 Finland

Caries of dentine

1.4

15.0

1157

9547

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

15.0

173

855

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.4

14.9

211

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

15.1

14.9

L43.8

ICD-10 Finland

Other lichen planus

4.1

14.8

141

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

14.8

1464

12638

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

14.8

222

1215

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

10.5

14.7

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

25.2

14.7

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

14.7

298

1804

N03AX12

ATC

gabapentin; oral

1.7

14.6

330

2062

L01

ICPC

Neck symptom/complaint

1.7

14.6

298

1807

R03AC02

ATC

salbutamol; inhalant

1.4

14.5

1099

9014

Z49.2

ICD-10 Finland

Other dialysis

8.9

14.4

SPAT1325

SPAT

Vaccination

1.5

14.4

749

5717

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.1

14.4

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

7.9

14.3

SPAT1260

SPAT

Consultation of another employee

1.6

14.3

386

2536

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

4.7

14.3

104

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

14.3

156

750

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

10.5

14.2

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

14.2

144

672

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

14.1

343

2191

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

5.5

14.0

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

5.5

14.0

A99

ICPC

Disease/condition unspecnature/site

2.0

14.0

181

936

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

14.0

565

4084

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

14.0

328

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

14.0

178

914

R42

ICD-10 Finland

Dizziness and giddiness

1.6

13.9

467

3236

A02BC04

ATC

rabeprazole; oral

2.0

13.9

196

1047

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

13.9

954

7668

M79.6

ICD-10 Finland

Pain in limb

1.4

13.9

742

5684

L15

ICPC

Knee symptom/complaint

1.6

13.9

451

3103

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

13.8

131

L84

ICD-10 Finland

Corns and callosities

3.3

13.8

213

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.2

13.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

13.8

1325

11303

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

20.2

13.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

13.8

166

835

SPAT1311

SPAT

Counselling and guidance related to occupational health

2.9

13.7

281

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.6

13.7

D06BX01

ATC

metronidazole; topical

1.8

13.7

232

1325

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

13.7

226

1277

UJF32

NOMESCO Finland

Coloscopy

1.5

13.7

544

3917

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

13.7

783

6078

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

13.5

112

471

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

13.5

132

605

E66.8

ICD-10 Finland

Other obesity

2.4

13.5

113

480

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

7.2

13.5

K13.78

ICD-10 Finland

Other change in the oral mucosa

3.5

13.5

180

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

13.4

172

885

L08

ICPC

Shoulder symptom/complaint

1.6

13.4

403

2719

R03BA05

ATC

fluticasone; inhalant

1.6

13.4

394

2644

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

13.3

126

570

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

13.3

143

685

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

13.3

980

7956

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.3

13.3

198

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

10.5

13.2

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

13.2

577

4236

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.8

13.2

295

SPAT1255

SPAT

Intravenous administration of medicine

2.1

13.1

150

737

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.8

13.1

148

D01AE16

ATC

amorolfine; topical

1.8

13.0

255

1527

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.9

12.9

135

M54.5

ICD-10 Finland

Low back pain

1.4

12.9

663

5029

N03AE01

ATC

clonazepam; systemic

2.2

12.9

133

627

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

7.7

12.9

UJC12

NOMESCO Finland

Flexible oesophagoscopy

7.0

12.9

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

12.9

1078

8935

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.1

12.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

12.7

947

7685

R06AX22

ATC

ebastine; oral

1.6

12.7

353

2333

S99

ICPC

Skin disease other

3.5

12.6

169

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

6.2

12.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

12.6

218

L20.0

ICD-10 Finland

Besnier prurigo

2.2

12.6

130

613

JN6AD

NOMESCO Finland

CT of torso and neck

4.8

12.5

L98.80

ICD-10 Finland

Hereditary mucoepithelial dysplasia

+∞

12.5

WX320

NOMESCO Finland

Spinalanesthesy

1.5

12.5

470

3337

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.3

12.5

197

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

10.1

12.5

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

12.5

500

3600

DAX08

NOMESCO Finland

Fitting of hearing aid

2.4

12.5

108

466

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

12.4

255

1548

J01FA10

ATC

azithromycin; systemic

1.4

12.4

1201

10170

R06AE09

ATC

levocetirizine; oral

1.7

12.3

280

1750

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.7

12.3

146

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

12.3

615

4626

196

Kela drug reimbursment

Paricalcitol and cinacalcet

11.7

12.3

J01MA14

ATC

moxifloxacin; systemic

1.9

12.3

191

1059

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

12.3

324

2110

R51.80

ICD-10 Finland

Headache

1.7

12.3

290

1831

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

12.3

535

3917

D05AX52

ATC

calcipotriol, combinations; topical

2.3

12.3

116

526

SPAT1360

SPAT

Extensive global examination

1.9

12.3

173

925

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.5

12.2

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

6.0

12.2

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.5

12.2

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.9

12.2

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.3

12.2

109

479

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.2

12.2

201

GD2SN

NOMESCO Finland

Lung ventilation SPECT

6.4

12.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

12.1

232

1376

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

3.2

12.1

196

J01AA02

ATC

doxycycline; systemic

1.4

12.1

1696

15261

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

12.0

212

1226

XQ817

NOMESCO Finland

21.4

12.0

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

10.1

12.0

N05BB01

ATC

hydroxyzine; systemic

2.1

12.0

140

697

ULC02

NOMESCO Finland

Hysteroscopy

2.2

11.9

123

577

9733

FHL

Excision of skin change in operating room or anesthesia

4.2

11.9

106

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

11.9

362

2443

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.0

11.8

156

814

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.9

11.8

126

TK810

NOMESCO Finland

Hemofiltration

7.1

11.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

11.8

740

5803

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

5.5

11.8

P01AB01

ATC

metronidazole; oral, rectal

1.4

11.8

814

6495

WX402

NOMESCO Finland

General anaesthesia

0.5

11.8

124

2209

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.3

11.8

109

487

D06BX02

ATC

ingenol mebutate; topical

4.0

11.8

117

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.1

11.7

140

700

GD1UN

NOMESCO Finland

Lung circulation SPECT

7.4

11.7

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

11.7

213

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

11.7

119

558

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

11.7

248

1522

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

11.7

100

430

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

11.6

133

655

L50.9

ICD-10 Finland

Urticaria, unspecified

2.6

11.6

319

A06AD11

ATC

lactulose; oral

1.6

11.6

296

1912

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

11.6

113

518

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.5

11.5

377

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

8.6

11.5

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

11.5

388

J20

ICD-10 Finland

Acute bronchitis

1.8

11.5

204

1184

WQ026

NOMESCO Finland

120.6

11.4

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

7.5

11.4

P01BA01

ATC

chloroquine; systemic

7.5

11.4

R03BA08

ATC

ciclesonide; inhalant

1.9

11.4

170

929

A03

ICPC

Fever

1.6

11.4

298

1934

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

2.0

11.3

140

714

WZA90

NOMESCO Finland

Other doctors statement

1.5

11.3

458

3297

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

11.3

288

1857

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

11.3

177

986

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

9.6

11.2

S01AA02

ATC

chlortetracycline; ophthalmic

6.2

11.2

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

11.2

333

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.5

11.2

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

11.2

215

1279

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.4

11.2

401

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.8

11.2

254

D05AX02

ATC

calcipotriol; topical

2.4

11.1

383

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.3

11.1

165

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

11.1

392

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

11.1

127

628

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

3.8

11.1

124

N06AB04

ATC

citalopram; systemic

1.5

11.0

438

3137

HA1AA

NOMESCO Finland

X-ray mammography

1.9

11.0

173

962

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.1

11.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.5

11.0

145

S76

ICPC

Skin infection other

2.2

10.9

111

518

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

10.9

1143

9720

B01AF01

ATC

rivaroxaban; oral

1.7

10.8

256

1616

A01AB09

ATC

miconazole; local oral

1.8

10.8

186

1066

D01BA02

ATC

terbinafine; oral; topical

1.5

10.8

496

3658

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.8

10.8

189

1091

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

10.8

354

2428

L21.0

ICD-10 Finland

Seborrhoea capitis

5.1

10.8

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

10.6

10.8

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

10.7

508

3769

Z42.4

ICD-10 Finland

Follow-up care involving plastic surgery of lower extremity

28.1

10.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.1

10.7

R06.2

ICD-10 Finland

Wheezing

2.3

10.7

439

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

21.6

10.7

R11

ICD-10 Finland

Nausea and vomiting

1.9

10.7

166

920

DFF59

NOMESCO Finland

Other assessment of balance

4.6

10.7

R35

ICD-10 Finland

Polyuria

2.0

10.6

132

672

7151

FHL

Kidney transplantation

60.3

10.6

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

60.3

10.6

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.0

10.6

142

744

B03XA01

ATC

erythropoietin; parenteral

6.0

10.6

R01AD09

ATC

mometasone; nasal

1.4

10.5

895

7352

J04BA02

ATC

dapsone; oral

11.3

10.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

10.5

231

1430

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.1

10.5

189

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

10.5

197

1163

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.4

10.5

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.3

10.5

664

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.9

10.4

155

847

L95.8

ICD-10 Finland

Other vasculitis limited to skin

+∞

10.4

5602

FHL

Internal fistula (eg Cimino)

+∞

10.4

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

10.4

270

1746

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

10.4

313

2103

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

10.4

229

1419

E000002

ATC

1.7

10.4

226

1397

P20

ICPC

Memory disturbance

1.7

10.4

242

1525

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

10.3

552

4188

DFF15

NOMESCO Finland

Speech audiometry

2.2

10.3

103

481

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.1

10.3

181

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

10.3

244

1542

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.9

10.3

215

QAJ10

NOMESCO Finland

Browlift

8.8

10.3

M86.6

ICD-10 Finland

Other chronic osteomyelitis

18.9

10.3

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

10.2

149

808

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

3.1

10.2

171

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.6

10.2

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

10.2

139

736

C01CA24

ATC

epinephrine; parenteral

2.0

10.2

127

651

D69.0

ICD-10 Finland

Allergic purpura

7.5

10.2

N30.0

ICD-10 Finland

Acute cystitis

1.6

10.2

290

1922

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

10.1

408

2927

SPAT1167

SPAT

Insertion of urinary catheter

2.6

10.1

284

WX199

NOMESCO Finland

Other local analgesia

2.8

10.0

236

L29.9

ICD-10 Finland

Pruritus, unspecified

2.9

10.0

207

M10.9

ICD-10 Finland

Gout, unspecified

2.0

10.0

125

640

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.8

10.0

110

D07XB01

ATC

flumetasone, combinations; topical

5.5

10.0

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

9.9

365

2566

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.5

9.9

306

M48.0

ICD-10 Finland

Spinal stenosis

1.6

9.9

248

1592

M03BX02

ATC

tizanidine; oral

1.3

9.8

1258

10953

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

9.8

255

1649

D02AX

ATC

Other emollients and protectives

2.6

9.8

282

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.7

9.8

112

L76

ICPC

Fracture: other

2.7

9.8

251

S82

ICPC

Naevus/mole

1.6

9.8

253

1637

L01AA01

ATC

cyclophosphamide; systemic

10.7

9.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

9.8

151

836

TEA00

NOMESCO Finland

Biopsy of lip

4.5

9.7

C08CA05

ATC

nifedipine; systemic

1.9

9.7

138

743

EKA10

NOMESCO Finland

Biopsy of cheek

3.1

9.7

166

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

4.4

9.7

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.0

9.7

121

622

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.1

9.6

173

T89

ICPC

Diabetes insulin dependent

2.4

9.6

318

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

8.4

9.5

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

9.5

142

779

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

9.1

9.5

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

15.1

9.5

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.1

9.5

109

541

SPAT1053

SPAT

Memory test

1.5

9.5

300

2036

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.1

9.5

158

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

9.5

345

2421

WX882

NOMESCO Finland

High dependency care

2.6

9.5

251

J01CF05

ATC

flucloxacillin; systemic

2.5

9.5

305

L43.9

ICD-10 Finland

Lichen planus, unspecified

3.2

9.4

148

L98.0

ICD-10 Finland

Pyogenic granuloma

30.1

9.4

A02BA02

ATC

ranitidine; systemic

1.5

9.4

399

2890

L98.8

ICD-10 Finland

Other specified disorders of skin and subcutaneous tissue

+∞

9.4

J01MA06

ATC

norfloxacin; oral

1.6

9.4

283

1903

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

3.3

9.4

143

QBJ00

NOMESCO Finland

Liposuction in trunk

12.4

9.4

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

8.1

9.3

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

9.3

124

654

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

9.3

104

509

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

9.2

255

1676

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

9.2

211

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

9.2

344

V03AE03

ATC

lanthanum carbonate; oral

13.7

9.2

9862

FHL

Facial skin shaping surgery (Faclift)

13.7

9.2

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

4.5

9.1

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

6.7

9.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

9.1

807

6633

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

7.7

9.1

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

7.7

9.1

W19

ICD-10 Finland

Unspecified fall

1.7

9.1

181

1087

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.7

9.1

104

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

3.8

9.1

N05BA12

ATC

alprazolam; oral

1.7

9.1

204

1272

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

9.1

101

495

R02

ICPC

Shortness of breath/dyspnoea

1.6

9.1

235

1520

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

5.1

9.1

-50

ICPC

Medication/prescr/renewal

2.1

9.1

447

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

5.4

9.0

L01BB01

ATC

15.6

9.0

D06BB04

ATC

podophyllotoxin; topical

2.2

9.0

439

D05AX03

ATC

calcitriol; topical

3.6

9.0

110

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.8

9.0

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.4

9.0

332

C10AC01

ATC

colestyramine; oral

2.7

9.0

233

PD5AD

NOMESCO Finland

CT of aorta

3.4

9.0

126

A04

ICPC

Weakness/tiredness general

1.6

9.0

257

1706

R06AX18

ATC

acrivastine; oral

2.5

9.0

266

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

9.0

334

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

6.5

8.9

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

8.9

406

2977

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

8.9

381

2761

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

8.9

253

1676

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.5

8.9

280

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

4.1

8.8

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.8

8.8

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.6

8.8

107

C07AB02

ATC

metoprolol; systemic

1.4

8.8

410

3019

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

8.8

452

3390

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.0

8.8

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

8.8

191

1177

JF2AD

NOMESCO Finland

Colon CT

9.5

8.8

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

8.8

275

A06AC51

ATC

ispaghula, combinations; systemic

2.0

8.7

107

544

K02.0

ICD-10 Finland

Caries limited to enamel

1.6

8.7

242

1593

JF2BD

NOMESCO Finland

Extensive colon CT

4.4

8.7

R78

ICPC

Acute bronchitis/bronchiolitis

2.7

8.7

225

WQ022

NOMESCO Finland

50.2

8.7

SPAT1097

SPAT

Recording of ECG

1.5

8.7

302

2095

ZZR00

NOMESCO Finland

Flap of skin

2.8

8.7

186

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

8.7

421

3128

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

8.7

206

1304

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

8.6

527

4076

-48

ICPC

Clarification/discussion RFE/demand

2.6

8.6

227

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

7.7

8.6

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

7.7

8.6

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

8.6

289

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.2

8.6

369

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

8.6

381

R03DA05

ATC

aminophylline; systemic, rectal

5.0

8.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

8.6

520

4013

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

8.5

126

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

16.3

8.5

-34

ICPC

Blood test

2.5

8.5

273

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.9

8.5

176

H3600, E103

ICD-10 Finland

4.3

8.5

WQ031

NOMESCO Finland

27.6

8.5

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

2.3

8.5

333

L30.0

ICD-10 Finland

Nummular dermatitis

2.3

8.5

333

L52

ICD-10 Finland

Erythema nodosum

6.0

8.4

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.8

8.4

138

782

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

8.4

121

656

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

8.4

464

3528

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

8.4

326

2314

L98.6

ICD-10 Finland

Other infiltrative disorders of skin and subcutaneous tissue

+∞

8.3

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

+∞

8.3

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

3.8

8.3

C03DA01

ATC

spironolactone; oral

1.6

8.3

204

1305

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

8.2

606

4827

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.0

8.2

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.6

8.2

222

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

8.2

101

514

ZZH31

NOMESCO Finland

Bone allograft, small pieces

4.8

8.2

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.4

8.2

285

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.3

8.2

325

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

14.5

8.2

N04BC05

ATC

pramipexole; oral

1.8

8.2

145

844

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.1

8.2

XQ899

NOMESCO Finland

Other assessment of skin

7.5

8.2

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

8.1

419

J05AB11

ATC

valaciclovir; oral

1.5

8.1

259

1762

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

5.7

8.1

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

8.1

332

G04BD12

ATC

mirabegron; oral

1.6

8.1

205

1321

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.1

428

3227

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

11.7

8.1

H03AA01

ATC

levothyroxine sodium; systemic

1.4

8.1

479

3683

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

8.1

149

M05BX04

ATC

denosumab; parenteral

1.9

8.0

106

556

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.8

8.0

172

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

8.0

106

557

C05AA08

ATC

fluocortolone; rectal, topical

1.5

8.0

286

1994

WX204

NOMESCO Finland

Axillary plexus blockaced

2.4

8.0

283

J01AA07

ATC

tetracycline; systemic

1.5

8.0

283

1967

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.1

8.0

428

N06AX11

ATC

mirtazapine; oral

1.3

8.0

610

4882

D01AC03

ATC

econazole; topical

1.9

8.0

123

681

B37.08

ICD-10 Finland

Other candidal stomatitis

5.5

8.0

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

8.0

239

N19

ICD-10 Finland

Unspecified kidney failure

2.4

8.0

277

NGQ20

NOMESCO Finland

Amputation of lower leg

7.2

8.0

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.0

7.9

SPAT1152

SPAT

Removal of foreign body from under the skin

2.5

7.9

240

R05FB02

ATC

cough suppressants and expectorants

1.3

7.9

770

6384

N05CF01

ATC

zopiclone; oral

1.3

7.9

634

5113

H02AB09

ATC

hydrocortisone; systemic

2.7

7.9

192

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

7.9

852

7167

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

7.8

400

SPAT1359

SPAT

Use of symptom diary

2.6

7.8

209

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

3.1

7.8

135

-42

ICPC

Electrical tracing

3.2

7.8

124

M02AA07

ATC

piroxicam; topical

1.3

7.8

736

6072

R05

ICD-10 Finland

Cough

1.4

7.8

378

2801

B35.3

ICD-10 Finland

Tinea pedis

2.2

7.8

347

S21

ICPC

Skin texture symptom/complaint

1.5

7.8

239

1615

L88

ICD-10 Finland

Pyoderma gangrenosum

45.1

7.7

PB1AT

NOMESCO Finland

Upper extremity artery PTA

45.1

7.7

M01AH02

ATC

rofecoxib; oral

1.5

7.7

267

1852

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

7.7

196

1263

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

7.7

154

928

T90

ICPC

Diabetes non-insulin dependent

1.4

7.7

430

3273

TJF80

NOMESCO Finland

Ostomy education

4.1

7.7

N03AX09

ATC

lamotrigine; oral

2.1

7.7

411

L85.80

ICD-10 Finland

Hudhorn

7.4

7.7

C02AC05

ATC

moxonidine; oral

2.0

7.6

438

JN4BD

NOMESCO Finland

Extensive body CT

1.6

7.6

208

1365

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.3

7.6

278

N06AX16

ATC

venlafaxine; oral

1.5

7.6

250

1712

SPAT1283

SPAT

Restricted health certificate

1.5

7.6

285

2008

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

8.0

7.6

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

7.6

379

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.5

7.6

1149

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

11.9

7.6

K59.0

ICD-10 Finland

Constipation

1.9

7.5

108

584

L14

ICPC

Leg/thigh symptom/complaint

1.7

7.5

143

850

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

7.5

432

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.8

7.5

JF2BB

NOMESCO Finland

Clongraphy with duple contrast

8.9

7.5

A08

ICPC

Swelling

2.0

7.5

433

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

7.5

161

992

WYA00

NOMESCO Finland

Screening and health check-up

3.1

7.5

123

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.7

7.5

179

A04AA01

ATC

ondansetron; systemic, rectal

1.8

7.5

135

788

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

7.1

7.5

U07

ICPC

Urine symptom/complaint other

1.8

7.5

115

638

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.5

7.5

221

L29.8

ICD-10 Finland

Other pruritus

4.0

7.5

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

3.9

7.4

D99

ICPC

Disease digestive system other

3.9

7.4

M01AB51

ATC

indometacin, combinations; oral, rectal

2.5

7.4

230

TGA30

NOMESCO Finland

Thoracocentesis

4.4

7.4

C07AB07

ATC

bisoprolol; oral

1.3

7.4

930

7957

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

5.0

7.4

PD4AD

NOMESCO Finland

CT of lower extremity arteries

6.5

7.4

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

7.7

7.4

JF1AD

NOMESCO Finland

Small bowel CT

5.3

7.4

S10

ICPC

Boil/carbuncle

1.9

7.4

105

570

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.9

7.4

XQ848

NOMESCO Finland

Dermatological photography

2.7

7.4

182

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

7.3

153

936

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

7.3

268

1879

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

7.3

283

SPAT1240

SPAT

Therapeutic discussion

1.6

7.3

191

1240

Z54.0

ICD-10 Finland

Convalescence following surgery

3.1

7.3

125

TUPEI

NOMESCO Finland

0.3

7.3

423

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.0

7.3

131

L98.1

ICD-10 Finland

Factitial dermatitis

+∞

7.3

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

10.9

7.3

S06.0

ICD-10 Finland

Concussion

1.6

7.3

184

1182

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

7.3

184

1182

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.6

7.3

190

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

9.4

7.3

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

9.4

7.3

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

7.3

157

969

PJA10

NOMESCO Finland

Exploration of lymph nodes

3.6

7.3

1470

FHL

Rectoscopy

4.5

7.3

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

3.0

7.3

126

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

7.2

674

5539

E000003

ATC

2.0

7.2

441

SPAT1125

SPAT

Stoma care and guidance

3.0

7.2

132

S19

ICPC

Skin injury other

2.1

7.2

366

TK820

NOMESCO Finland

Peritoneal dialysis

7.3

7.2

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

7.2

120

686

L73.8

ICD-10 Finland

Other specified follicular disorders

4.4

7.1

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.7

7.1

149

910

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

20.1

7.1

T82

ICPC

Obesity

2.2

7.1

314

N29

ICPC

Neurological sympt/complt other

2.9

7.1

143

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

7.1

110

611

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

7.1

438

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.3

7.1

275

M23.8

ICD-10 Finland

Other internal derangements of knee

2.1

7.1

341

A07EA06

ATC

budesonide; oral, local oral

2.2

7.1

329

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

7.0

112

NBG10

NOMESCO Finland

Acromioplastia

2.3

7.0

276

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

10.0

7.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

7.0

239

1652

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.2

7.0

321

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.6

7.0

176

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.5

7.0

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.1

7.0

113

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

3.6

7.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

7.0

173

1109

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

7.0

448

R15

ICD-10 Finland

Faecal incontinence

2.3

6.9

270

G04BD08

ATC

solifenacin; oral

1.7

6.9

134

802

R03BB04

ATC

tiotropium bromide; inhalant

1.6

6.9

182

1183

H25.1

ICD-10 Finland

Senile nuclear cataract

0.7

6.9

279

3739

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.9

6.9

140

R74

ICPC

Upper respiratory infection acute

1.3

6.9

498

3940

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

5.8

6.9

Z96.4

ICD-10 Finland

Presence of endocrine implants

13.8

6.9

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

13.8

6.9

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.8

6.9

110

618

J01CA08

ATC

pivmecillinam; oral

1.3

6.9

808

6839

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.0

6.9

453

SPAT1266

SPAT

Separate instruction to prepare for procedure

2.3

6.9

273

C10AA04

ATC

fluvastatin; oral

1.6

6.9

169

1082

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

6.8

341

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

4.8

6.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.4

6.8

L71.8

ICD-10 Finland

Other rosacea

3.4

6.8

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

8.3

6.8

R19.5

ICD-10 Finland

Other faecal abnormalities

3.1

6.8

115

Z37.0

ICD-10 Finland

Single live birth

0.4

6.8

724

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

3.2

6.8

104

QXA05

NOMESCO Finland

Skin division, unspecified location

6.7

6.8

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

6.8

517

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

4.5

6.8

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.1

6.8

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

5.3

6.8

L92.1

ICD-10 Finland

Necrobiosis lipoidica, not elsewhere classified

40.2

6.8

M32

ICD-10 Finland

Systemic lupus erythematosus

40.2

6.8

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

16.7

6.7

L81.9

ICD-10 Finland

Disorder of pigmentation, unspecified

16.7

6.7

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.9

6.7

478

D07AA02

ATC

hydrocortisone; topical

1.5

6.7

238

1656

8113

FHL

Fractional scraping

1.7

6.7

130

778

9734

FHL

Excision and local plastic or associated free skin grafting

4.7

6.7

L71.9

ICD-10 Finland

Rosacea, unspecified

2.7

6.7

160

S12

ICPC

Insect bite/sting

1.7

6.7

148

918

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.7

6.7

130

780

S06

ICPC

Rash localized

1.8

6.7

107

605

R03AA01

ATC

epinephrine; inhalant

22.6

6.7

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

6.7

251

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.1

6.6

106

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.0

6.6

123

R2110

NOMESCO Finland

Giving the first information

0.5

6.6

857

XX2CT

NOMESCO Finland

Other injection with CT guidance

6.4

6.6

R00.2

ICD-10 Finland

Palpitations

1.7

6.6

136

829

B01AB05

ATC

enoxaparin; parenteral

1.3

6.6

577

4690

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

7.8

6.6

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

7.8

6.6

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

6.6

475

B01AF02

ATC

apixaban; oral

1.6

6.6

174

1134

A10BX04

ATC

[U] exenatide; parenteral

3.5

6.6

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

6.6

482

3822

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

12.3

6.6

ND2BG

NOMESCO Finland

MRI of hand

12.3

6.6

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

6.6

175

1140

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.8

6.6

147

K90.0

ICD-10 Finland

Coeliac disease

2.2

6.6

266

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

6.6

253

1795

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.1

6.6

334

HA1BA

NOMESCO Finland

Extensive X-ray mammography

4.3

6.5

SPAT1281

SPAT

Other administrative function

1.6

6.5

153

968

J01EA01

ATC

trimethoprim; systemic

1.3

6.5

512

4101

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.3

6.5

259

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

6.5

302

L12

ICPC

Hand/finger symptom/complaint

1.5

6.5

256

1824

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.1

6.5

350

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.6

6.5

166

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.3

6.5

261

NFQ20

NOMESCO Finland

Amputation of femur

5.3

6.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

5.7

6.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

6.4

185

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.2

6.4

U14

ICPC

Kidney symptom/complaint

3.2

6.4

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

2.8

6.4

137

J01FA06

ATC

roxithromycin; oral

1.3

6.4

796

6769

N28

ICPC

Limited function/disability (N)

2.9

6.4

130

R53

ICD-10 Finland

Malaise and fatigue

1.4

6.4

380

2915

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

6.4

318

M01AH05

ATC

etoricoxib; oral

1.2

6.4

1166

10374

R05

ICPC

Cough

1.3

6.4

412

3203

NGE10

NOMESCO Finland

Incision or suture of capsule of knee joint

3.6

6.4

L70.0

ICD-10 Finland

Acne vulgaris

2.8

6.4

138

R05DA01

ATC

ethylmorphine; oral

1.6

6.4

162

1045

A10BH01

ATC

sitagliptin; oral

1.6

6.4

167

1089

L81

ICPC

Injury musculoskeletal NOS

2.5

6.3

179

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

8.2

6.3

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

6.3

236

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.3

302

2231

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

6.3

415

D09AB01

ATC

zinc bandage without supplements; topical

2.7

6.3

155

C09CA06

ATC

candesartan; oral

1.3

6.3

406

3155

UDM02

NOMESCO Finland

Sinoscopy

2.4

6.3

217

TCC30

NOMESCO Finland

Intubation of lacrimal canaliculus/duct

4.2

6.3

GAC00

NOMESCO Finland

Biopsy of pleura

5.5

6.3

N05AH04

ATC

quetiapine; oral

1.4

6.3

283

2065

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.3

1165

10375

F70

ICPC

Conjunctivitis infectious

2.4

6.3

207

G44.2

ICD-10 Finland

Tension-type headache

1.5

6.3

244

1735

QXA99

NOMESCO Finland

Other skin division, biopsy or local destruction, unspecified location

18.1

6.3

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

6.3

612

5047

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

+∞

6.3

WQ025

NOMESCO Finland

+∞

6.3

JN6PN

NOMESCO Finland

Leucocyte distribution isotope imaging

+∞

6.3

L98.60

ICD-10 Finland

Pseudolymphoma of the skin

+∞

6.3

L98.5

ICD-10 Finland

Mucinosis of skin

+∞

6.3

L98.69

ICD-10 Finland

Other infiltrative disease of the skin and subcutaneous tissue

+∞

6.3

S08

ICPC

Skin colour change

1.9

6.2

493

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

4.3

6.2

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

6.2

101

574

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

7.0

6.2

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

6.2

543

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.4

6.2

SPAT1373

SPAT

Combined screening in early pregnancy

3.4

6.2

H04AA01

ATC

glucagon; nasal, parenteral

2.6

6.2

158

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

3.0

6.2

112

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.6

6.2

165

A23

ICPC

Risk factor NOS

1.7

6.2

132

815

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.7

6.2

150

O36.8

ICD-10 Finland

Maternal care for other specified fetal problems

3.5

6.2

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

6.2

359

2741

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

6.2

546

B01AA03

ATC

warfarin; systemic

1.4

6.2

355

2707

H25.0

ICD-10 Finland

Senile incipient cataract

1.7

6.2

120

722

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

6.2

233

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

6.2

106

615

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

6.2

428

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.3

6.1

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

6.1

195

I50

ICD-10 Finland

Heart failure

2.3

6.1

234

A10AE04

ATC

insulin glargine; parenteral

1.6

6.1

160

1041

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

6.1

328

2473

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

6.1

255

D07XB05

ATC

dexamethasone, combinations; topical

2.4

6.1

215

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.1

415

3249

WX290

NOMESCO Finland

Other blockade of nerve

1.3

6.1

800

6841

R52.9

ICD-10 Finland

Pain, unspecified

1.6

6.1

150

959

DAB00

NOMESCO Finland

Excision of lesion of auricle

3.5

6.1

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

6.1

114

677

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.3

6.1

224

XG466

NOMESCO Finland

Sleep oxymetry

2.1

6.1

315

L28.0

ICD-10 Finland

Lichen simplex chronicus

3.6

6.1

XKD00

NOMESCO Finland

Uroflowmetry

1.4

6.1

267

1942

ZZH30

NOMESCO Finland

Bone allograft

12.5

6.1

2165A

ICD-9 Finland

Benign neoplasm of skin, Skin of trunk, except scrotum[VARTALON IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]

12.5

6.1

G01AF02

ATC

clotrimazole; vaginal

2.0

6.1

379

N32.0

ICD-10 Finland

Bladder-neck obstruction

3.9

6.1

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.7

6.1

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

3.7

6.1

PA6AD

NOMESCO Finland

CT of neck arteries

3.1

6.1

1008

NOMESCO Finland

8.6

6.1

N41.1

ICD-10 Finland

Chronic prostatitis

2.5

6.1

171

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

6.0

437

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.2

6.0

258

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.8

6.0

124

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

6.7

6.0

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.0

329

2489

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.7

6.0

125

764

SPAT1043

SPAT

Audiometry

1.5

6.0

197

1350

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.0

731

6189

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019225) pH of Specimen

1036

2142

7.52

307.65

6.7

4.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1200

2623

7.83

307.65

5.2

4.5

33.3

32.6

1.03

892

1735

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

488

776

7.56

304.04

5.9

3.6

24.7

24.9

mmol/l

0.84

458

720

(3022313) Gas panel - Capillary blood

510

904

6.82

285.83

5.7

3.4

—

(3013512) EKG study

1433

6144

4.09

265.61

5.4

3.8

—

(3009343) pH of Capillary blood

542

1245

5.27

227.42

5.7

3.4

7.4

—

150

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

544

1258

5.24

226.42

5.7

3.4

5.1

kpa

0.02

498

1157

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

526

1196

5.29

223.07

5.7

3.4

0.8

1.9

mmol/l

6.56

433

876

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

434

834

6.08

221.51

2.4

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

403

770

6.04

206.33

1.9

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

199

228

9.39

160.89

1.3

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1030

17055

0.33

159.02

21.0

17.0

13.9

13.7

6.08

1012

16661

(3008757) Leukocyte morphology finding [Identifier] in Blood

176

208

9.02

138.65

4.5

3.8

—

(40768443) Skin Pathology biopsy report

333

770

4.83

135.29

1.4

1.2

—

(3003338) MCHC [Mass/volume]

1117

17280

0.36

132.37

21.3

17.9

331.2

332.0

g/l

2.03

1102

17150

(3044889) 12 lead EKG panel

825

14575

0.35

128.25

3.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1027

5045

2.75

126.25

3.1

2.2

—

(3037121) Protein [Mass/volume] in Urine

308

719

4.74

123.30

5.2

3.1

0.3

g/l

0.29

118

277

(3025468) Yersinia sp identified in Specimen by Organism specific culture

177

250

7.54

119.94

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

178

254

7.46

119.52

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

177

252

7.48

119.08

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

176

250

7.49

118.65

1.5

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

183

272

7.18

118.41

2.6

2.2

30.7

23.2

mg/l

0.74

(3005988) Vibrio sp identified in Specimen by Organism specific culture

176

251

7.46

118.22

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

175

250

7.45

117.36

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

436

1367

3.65

116.43

3.3

3.0

4.2

4.1

e9/l

0.37

257

1069

(42870588) Differential panel, method unspecified - Blood

1243

6935

2.56

114.98

8.7

5.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

824

3873

2.68

107.34

1.9

1.7

896.4

1179.8

nmol/l

18.21

588

2894

(3038026) Centromere Ab [Units/volume] in Serum

131

159

8.64

100.72

1.2

1.1

7.9

78.4

u/ml

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

129

155

8.72

99.98

1.2

1.1

59.7

67.3

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

129

155

8.72

99.98

1.2

1.1

52.6

63.0

u/ml

0.13

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

126

148

8.91

99.43

1.2

1.1

16.9

4.1

u/ml

—

(40768804) Tissue Pathology biopsy report

1350

8391

2.31

90.94

2.8

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1285

7830

2.31

90.68

5.0

3.6

42.2

109.2

ng/l

0.59

1007

5381

(3017354) Segmented neutrophils/100 leukocytes in Blood

132

185

7.47

89.81

4.1

3.4

58.1

56.9

0.18

107

117

(3044640) Blood type and Crossmatch panel - Blood

1127

6602

2.28

86.10

3.1

2.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

11.81

85.60

2.3

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

11.82

84.71

2.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

11.82

84.71

2.3

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1427

9450

2.18

77.55

8.0

5.7

1.2

mmol/l

16.20

1197

8504

(3019069) Monocytes/100 leukocytes in Blood

1443

9606

2.18

77.26

9.4

6.0

8.5

8.6

1.33

1328

8961

(3006504) Eosinophils/100 leukocytes in Blood

1438

9561

2.17

77.22

8.5

5.7

2.9

2.8

0.41

1314

8882

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

9.69

76.31

2.3

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

9.69

76.31

2.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

9.69

76.31

2.3

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

9.69

76.31

2.3

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

1450

9711

2.16

75.91

7.9

5.6

58.2

57.3

2.16

1330

9052

(3002030) Lymphocytes/100 leukocytes in Blood

1464

9860

2.16

75.29

8.9

5.8

27.4

27.9

0.90

1329

9154

(3022096) Basophils/100 leukocytes in Blood

1396

9279

2.13

73.70

8.6

5.7

0.7

0.77

1280

8626

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

185

431

4.55

73.39

1.6

1.3

—

(3032080) INR in Blood by Coagulation assay

1273

8325

2.07

68.34

7.3

9.2

1.3

inr

0.21

144

2407

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

995

5945

2.11

68.12

3.6

3.0

1903.8

1402.2

ng/l

2.09

764

5073

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1789

13296

2.19

67.87

4.9

3.0

53.8

47.4

u/l

1.93

1610

12311

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

207

566

3.90

66.23

2.1

1.6

—

(3013115) Eosinophils [#/volume] in Blood

1503

10519

2.06

66.10

8.0

5.7

0.2

e9/l

0.26

1356

9192

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

9.45

65.93

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

9.45

65.93

1.5

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

167

391

4.50

65.75

1.3

1.2

8.1

9.2

u/ml

—

(3004809) Band form neutrophils/100 leukocytes in Blood

145

307

4.95

64.52

3.9

3.3

1.7

1.4

0.34

120

236

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

536

2561

2.39

62.93

6.0

6.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

161

383

4.42

62.07

1.2

2.5

4.9

u/ml

0.41

(3013707) Erythrocyte sedimentation rate by Westergren method

1964

15378

2.26

61.96

6.7

4.0

13.8

12.4

mm/h

3.57

1765

14182

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

183

484

4.00

61.26

1.3

1.2

2.8

3.9

u/ml

0.51

(3006315) Basophils [#/volume] in Blood

1446

10154

2.00

60.87

7.8

5.5

0.0

e9/l

3.07

1345

8737

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

184

491

3.96

60.83

1.3

1.2

7.5

8.0

u/ml

0.03

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1472

10423

1.99

60.23

10.9

6.3

1.2

mmol/l

9.46

1261

8734

(3001604) Monocytes [#/volume] in Blood

1434

10111

1.97

58.83

7.7

5.5

0.6

e9/l

0.30

1338

8695

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

106

184

5.97

58.65

2.3

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

186

529

3.72

56.07

1.3

1.2

16.6

34.2

u/ml

0.62

(3019198) Lymphocytes [#/volume] in Blood

1453

10400

1.94

55.76

7.8

5.6

1.9

e9/l

1.19

1336

9137

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

979

6171

1.96

54.74

2.5

2.1

207.5

220.9

u/l

0.16

907

5754

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2003

16134

2.18

53.75

11.6

7.3

79.0

78.3

u/l

0.23

1850

15124

(3044927) Protein electrophoresis panel - Urine

108

209

5.35

53.20

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

106

202

5.43

53.10

2.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

115

7.15

53.07

1.5

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1259

8702

1.89

52.59

2.7

2.2

78.7

77.8

nmol/l

0.47

1034

7758

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

165

5.94

52.51

2.2

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

165

5.94

52.51

2.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

165

5.94

52.51

2.2

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

114

7.12

52.22

1.5

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

995

6423

1.91

50.85

3.3

2.5

55.4

57.8

u/l

1.21

888

5914

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

10.79

50.69

3.4

2.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

856

5263

1.95

50.62

2.6

2.2

3.4

3.0

mg/l

5.96

688

4476

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

306

1242

2.67

50.09

1.7

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1815

14278

1.97

49.39

7.2

4.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

186

5.44

49.30

5.2

2.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1234

8596

1.85

49.12

2.3

2.0

104.6

94.5

pmol/l

7.40

700

4389

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

9.15

49.07

4.3

2.2

505.0

3658.7

u/ml

—

(3000494) Fungus identified in Specimen by Culture

469

2333

2.24

48.94

1.7

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1461

10778

1.85

47.80

8.0

6.1

10.5

11.4

umol/l

1.30

1359

10189

(3037522) Nuclear Ab [Titer] in Serum

504

2635

2.14

46.18

1.5

1.3

559.5

517.7

titre

0.22

157

539

(3021589) Normoblasts [#/volume] in Blood

553

9124

0.50

45.66

11.6

9.3

0.0

e9/l

1.09

477

7428

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1342

9782

1.80

44.28

4.2

3.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

445

2270

2.17

43.17

4.9

4.1

237.9

250.0

u/l

0.78

406

2139

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

586

3319

2.00

42.85

2.4

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

344

1588

2.35

42.43

5.1

3.5

103.3

86.5

ng/l

2.01

282

1368

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

189

646

3.08

42.37

2.2

2.1

289.1

561.0

ug/l

1.51

174

604

(3032057) Clostridioides difficile [Presence] in Stool

10.90

40.91

2.6

2.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

7.59

40.78

30.0

23.8

95.3

123.5

ug/l

2.36

(3003458) Phosphate [Moles/volume] in Serum or Plasma

489

2640

2.06

40.64

9.7

5.0

1.1

1.0

mmol/l

1.12

444

2437

(3007853) Bacteria identified in Skin by Aerobe culture

421

2175

2.12

39.24

2.3

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

350

1680

2.26

39.22

2.9

2.5

66.5

70.7

e9/l

1.75

314

1281

(3042936) Bacteria identified in Isolate by Culture

501

2763

2.02

39.11

2.5

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1558

12121

1.75

38.61

5.0

4.5

6.7

mmol/l

0.25

1472

11300

(3013650) Neutrophils [#/volume] in Blood by Automated count

1539

11947

1.74

38.28

10.5

8.7

4.0

4.1

e9/l

0.46

1417

10400

(3014271) Vancomycin [Susceptibility]

106

6.27

38.27

2.8

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

104

262

4.10

37.09

1.4

29.1

28.2

u/l

0.09

213

(4146454)

228

4.34

37.00

2.9

2.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

185

678

2.87

36.55

3.4

2.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

13.36

34.85

1.8

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

304

1448

2.25

34.50

3.5

2.6

10.0

10.5

g/l

1.39

263

1314

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

369

1900

2.10

34.39

2.8

2.2

0.2

g/l

0.47

337

1770

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

270

1232

2.33

33.88

1.3

39.3

50.6

au/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

169

620

2.85

33.29

1.5

80.7

133.8

titre

—

(3020779) Urea [Moles/volume] in Serum or Plasma

342

1736

2.12

33.01

13.2

6.7

11.0

9.7

mmol/l

2.76

321

1650

(3018418) pH of Serum or Plasma

350

6172

0.50

32.14

5.0

3.8

7.4

0.02

1185

(36660697) Celiac disease serology panel - Serum

314

1561

2.16

31.93

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

121

5.31

31.29

3.1

2.0

516.7

722.0

e6/l

1.65

(4015189)

7.89

30.67

2.2

2.4

—

(3045424) Erythrocytes [Presence] in Urine

114

349

3.37

30.60

1.6

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

148

529

2.91

30.56

2.2

1.5

1.1

1.2

g/l

1.84

141

503

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

193

795

2.55

30.24

1.9

1.8

1.7

ug/l

0.07

149

705

(3031040) Bacteria [#/volume] in Urine by Automated count

1679

13772

1.66

29.99

6.2

4.4

8515.9

1981.8

e6/l

—

209

(3023368) Bacteria identified in Blood by Culture

813

5577

1.68

29.83

4.4

4.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

281

1375

2.17

29.66

2.6

2.4

11.6

22.9

au/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

142

513

2.87

28.75

2.2

1.5

0.2

g/l

1.28

135

488

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

271

3.60

28.42

3.8

2.6

21087.1

2439.9

u/ml

0.46

(3027945) Reticulocytes/100 erythrocytes in Blood

404

2289

1.91

28.36

2.8

2.5

1.8

0.07

326

2018

(3002179) Metamyelocytes/100 leukocytes in Blood

305

1566

2.08

28.36

4.4

3.6

1.2

0.6

0.97

119

333

(3004789) Transferrin [Mass/volume] in Serum or Plasma

485

2913

1.82

28.32

3.4

2.3

2.4

2.3

g/l

0.17

433

2695

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

112

357

3.24

28.17

8.0

4.5

527.0

962.7

iu/ml

0.45

(3022948) Iron [Moles/volume] in Serum or Plasma

515

3163

1.79

27.88

3.4

2.3

11.9

13.1

umol/l

3.56

458

2920

(3026250) Tacrolimus [Mass/volume] in Blood

6.67

27.67

43.5

29.0

6.2

7.3

ug/l

2.64

(36304419) Bacteria [Presence] in Urine

315

5527

0.51

27.63

3.8

2.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

455

2700

1.84

27.57

3.4

2.4

20.4

22.8

3.65

385

2310

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2157

19123

1.89

27.36

6.2

4.8

1.9

2.1

mu/l

1.04

1865

17432

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

193

833

2.43

27.33

2.3

1.9

42.2

38.6

u/l

1.65

169

732

(3007164) IgA [Mass/volume] in Serum or Plasma

597

3844

1.72

27.32

1.6

1.4

2.3

2.4

g/l

0.53

342

2304

(4035726)

343

1868

1.97

27.00

1.5

1.4

—

(3011412) CD3 cells [#/volume] in Blood

171

4.24

26.90

3.1

2.0

1.7

1.1

e9/l

1.61

105

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

119

4.97

26.76

1.3

1.4

34.4

69.3

titre

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

191

4.02

26.39

1.9

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

410

2388

1.86

26.27

2.9

2.3

162.0

128.5

ug/g

0.98

269

1862

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

199

887

2.35

26.20

1.8

1.6

1.5

g/l

0.34

173

766

(3049717) Cytology report of Urine Cyto stain

176

745

2.46

25.98

2.9

2.6

—

(3048879) Bone marrow aspiration report

7.06

25.88

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2180

19489

1.88

25.56

16.3

13.0

77.6

80.1

ml/min/173m2

5.79

1918

16022

(3021960) Folate [Moles/volume] in Serum or Plasma

716

4916

1.64

25.37

1.7

1.5

20.0

20.8

nmol/l

0.59

526

4170

(4024509)

207

3.81

25.13

1.9

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

305

1637

1.98

24.94

4.5

3.8

0.1

0.51

127

427

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

278

1447

2.04

24.78

1.9

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

103

338

3.13

24.70

2.3

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.35

24.68

2.3

2.5

—

(40768797) Stomach Pathology biopsy report

472

2922

1.76

24.54

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

144

569

2.62

24.53

1.4

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1147

8849

1.54

24.36

3.6

2.7

172.2

123.1

ug/l

2.14

1003

8162

(3028026) IgM [Mass/volume] in Serum or Plasma

233

1145

2.14

24.19

2.2

1.8

1.3

1.4

g/l

0.78

193

1038

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

7.15

24.18

1.6

1.5

0.4

ug/l

0.01

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

138

4.43

24.13

1.4

1.5

24.2

18.8

u/ml

0.34

(3026493) Urate [Moles/volume] in Serum or Plasma

754

5299

1.60

24.05

3.9

2.5

1266.0

5982.6

umol/l

7.29

630

4576

(3017143) Hepatitis C virus Ab [Presence] in Serum

360

2078

1.85

23.57

2.0

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

312

1723

1.93

23.41

4.5

3.7

1.1

0.8

0.53

128

467

(3036481) Cortisol [Moles/volume] in Serum or Plasma

331

1867

1.89

23.28

2.8

2.1

345.9

370.5

nmol/l

1.57

289

1698

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

667

4587

1.62

23.12

1.6

1.7

18164487.1

33193376.7

pmol/l

0.34

512

3799

(3018095) Leukocytes [#/volume] in Urine

488

7259

0.59

23.02

4.3

3.5

76.8

115.0

e6/l

0.74

349

5120

(3030467) Casts [#/volume] in Urine by Automated count

348

5662

0.55

22.96

3.9

3.0

0.3

0.5

e6/l

3.06

269

4264

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

5.13

22.62

1.3

1.1

26.4

22.2

u/l

0.27

(3004588) Protein electrophoresis panel - Serum or Plasma

261

1371

2.01

22.61

2.2

2.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

125

483

2.67

22.27

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

400

6199

0.58

21.87

4.0

3.1

63.9

87.3

e6/l

0.39

327

4758

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

5.07

21.87

1.3

1.1

93.5

83.5

u/l

0.31

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1852

16061

1.58

21.73

4.9

4.1

15.2

14.8

pmol/l

8.55

1578

14542

(40761535) Cells panel - Urine sediment

299

1669

1.90

21.65

5.5

3.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

104

378

2.83

20.84

1.5

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

637

4432

1.59

20.66

1.3

1.9

1.5

u/ml

0.29

1171

(3042631) Mycobacterium sp identified in Specimen

267

3.18

20.61

3.0

2.4

—

(1761868) Lipid panel - Serum or Plasma

488

7074

0.62

19.99

2.6

2.8

—

(4010399)

261

1432

1.92

19.85

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

284

4725

0.55

19.76

4.5

3.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1127

8931

1.47

19.52

6.7

4.5

34.7

35.4

g/l

4.21

1013

8286

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

125

516

2.50

19.47

2.7

2.1

13.4

11.6

mg/l

1.23

114

473

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2105

18983

1.66

19.38

7.4

5.7

40.3

39.7

mmol/mol

1.65

1809

17465

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

117

471

2.56

19.21

2.2

1.5

—

(3028433) Virus identified in Specimen by Culture

5.71

18.99

1.5

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2247

20662

1.81

18.84

23.5

13.7

18.5

23.8

mg/l

14.31

1942

16305

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.36

18.26

1.6

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

112

457

2.52

17.89

2.3

1.5

—

(3022145) Colonoscopy Study observation

367

2312

1.69

17.46

1.4

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

5.56

17.43

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

930

7215

1.46

17.37

3.5

3.3

2.3

2.4

mmol/l

0.61

647

6284

(3009508) Creatinine [Moles/volume] in Urine

845

6438

1.47

17.33

4.3

3.1

6.9

7.3

mmol/l

1.66

662

5389

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

121

4.02

17.19

1.2

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

840

6403

1.47

17.14

5.1

3.9

10.5

8.2

mg/mmol

0.83

519

3961

(3019550) Sodium [Moles/volume] in Serum or Plasma

2297

21370

1.85

17.03

24.3

15.9

139.7

mmol/l

0.02

2209

20810

(3012516) Albumin [Mass/volume] in Urine

803

6085

1.47

16.82

4.4

3.2

54.5

310.4

mg/l

5.73

500

3758

(3000093) Morphology [Interpretation] in Blood Narrative

175

3.43

16.73

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2300

21428

1.84

16.66

24.5

16.0

4.0

mmol/l

4.83

2202

20837

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

27.72

16.49

6.0

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2131

19464

1.62

16.47

5.2

3.9

1.3

mmol/l

0.59

1845

17711

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

6.14

16.39

1.0

—

(3005570) Glucose [Moles/volume] in Urine

219

3.12

16.25

1.7

2.1

—

(3002256) Pathology report gross observation

409

2698

1.62

16.16

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

130

599

2.23

15.82

1.4

284.0

286.8

ug/g

0.06

349

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2183

20105

1.64

15.74

6.5

4.6

6.0

5.9

mmol/l

0.39

1862

18252

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

261

2.89

15.73

1.0

1.1

1.7

1.5

g/l

1.45

234

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.66

15.17

2.1

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

395

2637

1.59

14.75

31.0

24.8

1.4

1.3

inr

0.39

377

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

398

2668

1.58

14.60

1.9

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2335

21984

1.85

14.51

16.2

10.2

25.5

25.4

u/l

0.09

2195

21180

(3026389) Candida sp identified in Specimen by Organism specific culture

257

2.81

14.42

1.4

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

102

3.97

14.15

1.9

13.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

272

1671

1.70

14.08

2.5

2.7

66.3

66.5

g/l

0.10

216

1521

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.97

14.02

1.5

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.97

14.02

1.5

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.97

14.02

1.5

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.86

13.99

1.3

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

4.16

13.94

1.1

3.5

9.8

u/ml

—

(3025159) Blasts/100 leukocytes in Blood

255

1551

1.72

13.68

4.2

3.8

0.0

0.3

0.67

120

365

(40761511) CBC panel - Blood by Automated count

2288

21470

1.72

13.63

23.8

13.1

—

(40761536) Microorganisms panel - Urine sediment

1801

0.42

13.51

6.1

3.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

129

3.53

13.49

1.3

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

25.88

13.36

1.6

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

4.04

13.09

1.2

1.1

47.4

9.1

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

132

3.45

13.04

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.14

12.68

1.5

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

5.50

12.59

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.50

12.59

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.50

12.59

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.50

12.59

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

288

4315

0.62

12.53

3.3

2.5

4.6

6.0

e6/l

2.03

248

3771

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

594

4453

1.44

12.52

1.7

1.8

1.0

1.2

mg/l

1.89

416

3409

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

491

3550

1.48

12.51

1.3

41.2

37.1

iu/ml

0.18

136

1125

(40758558) Short blood count panel - Blood

372

5270

0.65

12.50

7.6

6.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

156

3.18

12.48

1.1

1.0

309.1

289.2

mg/l

0.63

139

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

213

3428

0.59

12.44

3.1

2.6

1.0

1.2

e6/l

0.84

136

1938

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

122

604

2.07

12.41

2.0

1.6

0.6

10.5

iu/ml

0.46

115

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

200

1167

1.78

12.41

1.6

1.5

—

(3017704) Immunofixation for Urine

117

3.55

12.39

1.7

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

7.77

12.29

1.5

1.1

—

(3037756) Immunofixation for Serum or Plasma

442

2.24

12.18

2.0

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

26.82

12.04

1.6

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

102

479

2.18

11.90

1.8

1.7

11007.6

14446.5

e6/l

0.52

350

(21494815) CD4 cells/100 lymphocytes in Specimen

156

3.12

11.83

2.0

1.9

24.9

46.7

5.88

(3005322) IgE [Units/volume] in Serum or Plasma

206

1229

1.74

11.83

1.4

1.2

239.3

211.3

u/ml

0.18

177

1130

(40768446) Kidney Pathology biopsy report

4.77

11.65

1.9

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

262

3950

0.62

11.62

4.9

3.7

326.9

358.4

ng/l

0.09

180

3071

(3044009) aPTT.lupus sensitive (LA screen)

8.38

11.49

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

120

609

2.02

11.44

2.2

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

109

534

2.09

11.43

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

109

539

2.07

11.15

1.8

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

142

771

1.89

11.13

1.4

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

246

2.60

11.12

2.1

1.6

51.5

59.0

0.76

157

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

8.79

11.12

1.5

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

173

2.93

11.09

1.4

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

5.04

10.99

1.5

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2160

20180

1.49

10.98

5.8

4.4

1.5

mmol/l

0.48

1880

18503

(3012095) Magnesium [Moles/volume] in Serum or Plasma

456

3326

1.45

10.97

4.1

3.2

0.8

mmol/l

0.76

422

3103

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

609

7735

0.72

10.95

4.6

3.8

—

(3019150) Specific gravity of Urine by Refractometry

304

4377

0.65

10.83

5.2

4.0

1.0

kg/l

0.44

102

653

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2173

20339

1.50

10.81

5.6

4.4

4.6

4.7

mmol/l

2.76

1901

18760

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

268

2.50

10.77

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

105

520

2.06

10.71

1.1

1.2

95.0

89.3

titre

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

206

3228

0.61

10.69

3.3

2.8

2.3

2.8

e6/l

0.47

131

1748

(40758292) HTLV I+II Ab panel - Serum

6.58

10.63

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

189

2.79

10.56

1.2

59.2

54.3

u/l

0.18

131

(3035350) Ketones [Presence] in Urine by Test strip

835

10057

0.75

10.44

4.2

3.6

0.0

estimate

0.00

125

1914

(3021601) Nitrite [Presence] in Urine by Test strip

839

10091

0.75

10.36

5.9

4.9

0.0

estimate

0.50

128

1930

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

462

3415

1.43

10.29

1.3

1.2

14.7

12.8

u/ml

0.17

114

1295

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.70

10.18

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

525

2.02

10.09

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

119

3.23

10.00

1.0

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

271

3937

0.65

10.00

3.0

2.5

mmol/l

0.23

243

3478

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

183

1115

1.69

9.75

2.5

2.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

4.80

9.53

1.4

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

410

5460

0.70

9.52

4.6

3.9

0.0

estimate

1.08

124

1878

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

155

2.87

9.49

1.8

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

108

3.27

9.44

1.0

1.1

1.0

ratio

—

(3019174) dRVVT (LA screen)

7.03

9.29

1.3

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

7.68

9.28

7.4

5.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

116

3.13

9.07

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

116

3.13

9.07

1.0

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1615

0.50

8.96

3.2

2.7

62.8

66.4

ml/min/173m2

0.38

648

(3010813) Leukocytes [#/volume] in Blood

2382

22912

1.73

8.92

33.2

20.5

6.9

6.7

e9/l

1.64

2326

22237

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

425

2.06

8.88

1.8

1.7

47.9

41.2

nmol/l

1.08

407

(3024731) MCV [Entitic volume]

2381

22903

1.72

8.87

33.0

20.4

91.3

91.1

1.29

2332

22561

(3009261) Glucose [Presence] in Urine by Test strip

864

10207

0.77

8.86

4.3

3.6

0.0

estimate

0.80

123

1881

(3035941) MCH [Entitic mass]

2381

22904

1.72

8.85

32.9

20.4

30.3

0.61

2332

22559

(3026361) Erythrocytes [#/volume] in Blood

2381

22905

1.72

8.84

33.1

20.5

4.4

4.5

e12/l

7.28

2326

22236

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

4.68

8.82

1.5

1.1

—

(3007461) Platelets [#/volume] in Blood

2380

22895

1.72

8.80

33.1

20.5

252.7

252.0

e9/l

0.20

2327

22288

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

168

2.71

8.74

1.1

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

2381

22914

1.71

8.70

33.3

20.6

132.6

134.5

g/l

8.41

2335

22571

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.03

8.65

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

499

1.96

8.62

2.6

3.4

1.8

1.5

mg/l

1.87

457

(3021788) Differential panel - Synovial fluid

350

2.15

8.57

1.8

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.82

8.51

1.6

1.2

43.2

38.4

g/l

0.87

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

452

1.98

8.19

2.4

3.4

77.4

914.9

u/ml

0.85

420

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.23

8.19

1.3

1.2

320.5

74.4

ug/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

189

1216

1.60

8.15

2.5

2.1

10.5

12.5

nmol/l

2.41

158

1068

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

153

2.71

8.00

1.2

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.09

7.99

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

251

1728

1.50

7.99

2.2

1.9

—

(3025941) Bacteria identified in Stool by Culture

176

1121

1.61

7.92

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

3.60

7.85

1.4

1.1

—

(3042733) HLA Ab [Presence] in Serum

4.34

7.68

5.1

4.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.75

7.64

2.8

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

148

2322

0.61

7.61

2.1

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1395

12477

1.26

7.61

3.0

2.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2183

20736

1.40

7.34

5.6

4.9

2.6

2.8

mmol/l

5.85

1897

19008

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

248

2.24

7.22

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

138

2169

0.62

7.15

4.7

3.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

315

2.09

7.13

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.27

7.10

1.6

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.68

7.06

1.1

1.0

—

(3003181) Sodium [Moles/volume] in Urine

365

2.00

7.01

1.5

1.3

59.9

62.7

mmol/l

0.22

290

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.21

6.97

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.86

6.93

1.7

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

119

2.80

6.90

1.3

1.4

1.3

1.2

nmol/l

0.03

(3037556) Urate [Mass/volume] in Serum or Plasma

3.46

6.84

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

120

1913

0.61

6.60

2.7

2.3

36.6

40.4

u/l

0.26

103

1642

(3009214) Lutropin [Units/volume] in Serum or Plasma

460

1.85

6.53

1.4

1.3

11.8

10.8

u/l

0.28

376

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

368

1.96

6.51

1.3

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

107

1742

0.60

6.41

5.1

3.4

1.2

mmol/l

0.04

1511

(3026782) Osmolality of Urine

306

4034

0.73

6.38

3.6

2.6

522.8

547.3

mosm/kgh2o

1.26

262

3435

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

197

2.31

6.36

2.5

2.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

110

663

1.69

6.19

2.3

3.1

0.3

0.4

u/ml

0.13

375

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

106

637

1.69

6.04

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

118

730

1.65

6.02

1.5

1.7

4.7

3.9

mg/l

0.22

520

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

110

1751

0.61

6.02

4.9

3.0

207.6

198.1

ng/l

0.10

100

1584

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.54

5.98

1.0

1.2

—

(40768793) Breast Pathology biopsy report

541

1.75

5.96

1.4

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.27

5.95

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

158

1051

1.54

5.95

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

773

0.43

5.86

4.2

3.4

4844.5

5400.6

u/ml

0.03

654

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

375

1.89

5.86

1.3

—

11.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.52

5.80

1.1

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

236

1711

1.42

5.76

2.3

2.4

5.8

7.0

ug/l

0.71

160

1508

(3010144) Erythrocytes [#/volume] in Synovial fluid

194

2.24

5.70

2.0

1.4

89944.9

107132.6

e6/l

0.07

132

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

299

2262

1.37

5.67

3.3

4.1

8.2

21.6

ug/l

1.94

241

1848

(3045414) Leukocytes [Presence] in Urine

146

966

1.54

5.65

1.7

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

257

2.04

5.50

1.5

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

4.82

5.49

1.7

1.2

6.6

5.8

mmol/l

—

(44806071)

4.82

5.49

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

555

1.70

5.47

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

286

1.98

5.42

1.3

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

186

2.22

5.38

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.56

5.32

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

256

1909

1.38

5.31

2.3

2.1

—

(40762814) Titanium [Mass/volume] in Blood

4.02

5.17

2.3

2.2

3.8

3.4

ug/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

320

1.90

5.13

1.3

1.2

24.1

35.5

u/l

0.97

270

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

373

1.82

5.03

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

330

1.87

5.01

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

100

2.62

4.89

1.7

1.6

7.1

8.6

ug/l

0.40

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.00

4.83

1.4

1.5

15.8

13.7

pmol/l

0.56

(3014051) Protein [Presence] in Urine by Test strip

520

0.38

4.81

1.6

2.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

202

2.10

4.81

2.1

10.2

8.7

umol/l

0.14

142

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

5.02

4.77

2.3

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

466

5599

0.79

4.75

1.7

1.6

1.4

mmol/l

0.11

422

4693

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.95

4.71

1.1

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

179

1284

1.42

4.67

3.1

3.2

4.4

4.5

pmol/l

0.49

148

1139

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

622

1.60

4.59

2.2

3.5

2.1

1.5

ratio

0.47

(46235355) HIV 1 and 2 tests - Meaningful Use set

394

3194

1.28

4.55

2.1

1.8

—

(3025549) Creatine [Moles/time] in 24 hour Urine

4.78

4.53

1.9

1.4

—

(3045142) Bone marrow Pathology biopsy report

235

1.98

4.50

1.4

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.16

4.48

1.1

1.2

297.1

279.6

pmol/l

0.07

(3006462) Nitrate [Presence] in Urine

2.54

4.46

4.8

3.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

100

643

1.58

4.45

2.3

3.5

31.5

78.3

mg/l

1.41

532

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

665

5729

1.22

4.44

5.7

5.0

2.3

2.9

ug/l

1.19

579

5111

(3034860) Kappa light chains.free [Mass/volume] in Serum

100

644

1.58

4.42

2.3

3.5

59.7

148.9

mg/l

0.51

533

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.11

4.36

1.1

—

(3020891) Body temperature

805

0.53

4.34

4.9

4.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1265

0.62

4.31

8.6

9.3

93.8

93.9

0.08

1258

(3015171) Extractable nuclear Ab [Units/volume] in Serum

108

713

1.54

4.29

1.4

1.2

3.5

0.9

u/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.05

4.24

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

478

1.65

4.23

2.4

3.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

159

2.15

4.21

1.4

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1245

0.62

4.20

7.4

7.0

25.0

24.5

mmol/l

0.50

1154

(3001556) Androgen free Index in Serum or Plasma

6.94

4.16

1.1

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

135

2.24

4.09

1.8

1.9

16.2

13.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.36

4.09

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

129

2.26

4.06

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

3.35

4.04

1.0

1.5

—

(3006270) Folate [Moles/volume] in Blood

169

2.09

4.02

1.2

1.1

312.7

380.6

nmol/l

1.16

149

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.94

4.01

1.1

—

(4211845)

111

2.36

3.99

4.6

3.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

182

1348

1.38

3.98

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

105

2.39

3.98

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

3.03

3.96

1.1

1.5

50.4

62.4

mu/l

0.15

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

402

0.37

3.92

6.4

3.8

34.0

34.8

u/ml

0.01

394

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.73

3.92

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

185

2.01

3.88

1.2

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

389

1.69

3.88

3.0

2.9

30.5

35.0

umol/l

1.21

325

(3044290) Cell count panel - Cerebral spinal fluid

399

1.67

3.80

1.1

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.81

3.80

2.1

2.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.54

3.80

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

8.77

3.77

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

385

1.68

3.76

1.2

36.5

45.9

u/ml

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.01

3.70

1.3

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.64

3.65

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

277

1.78

3.59

1.2

—

(3024471) HLA-A [Type]

2.95

3.57

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

308

1.74

3.54

1.1

—

(3023410) Appearance of Cerebral spinal fluid

197

0.25

3.52

1.0

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.86

3.52

1.7

1.3

86.2

93.5

ng/l

—

(3010421) pH of Blood

559

0.50

3.51

3.8

3.9

7.4

0.23

454

(40768795) Lymph node Pathology biopsy report

194

1.92

3.43

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.35

3.41

1.1

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

539

1.54

3.39

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

507

1.56

3.39

2.8

3.1

24.9

24.8

mmol/l

0.08

433

(21494434) Karyotype in Bone marrow

195

1.91

3.39

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

178

2317

0.75

3.38

2.0

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.51

3.38

1.4

8.5

60.2

71.9

mg/l

0.33

(3019832) Treponema pallidum Ab [Presence] in Serum

202

1562

1.32

3.37

1.7

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.72

3.32

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.55

3.29

1.0

1.1

51.6

686.3

ng/l

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

176

1.94

3.29

1.5

1.4

2.6

3.0

g/l

0.78

123

(3027135) IgG subclass 1 [Mass/volume] in Serum

176

1.94

3.29

1.5

1.4

5.8

7.1

g/l

1.77

124

(3024139) IgG subclass 3 [Mass/volume] in Serum

176

1.94

3.29

1.5

1.4

0.3

0.4

g/l

2.09

123

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.79

3.25

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

103

2.24

3.22

1.0

1.3

37.6

51.3

pmol/l

0.39

(21494755) Public health laboratory ask at order entry panel

121

1658

0.72

3.22

1.4

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

435

1.58

3.18

3.8

3.2

0.8

nmol/l

0.55

344

(3012501) Base excess in Blood by calculation

460

0.47

3.18

3.9

4.2

3.2

2.5

mmol/l

0.41

313

(4034850)

693

0.57

3.18

12.8

9.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

289

1.71

3.15

2.1

1.7

1.0

0.9

g/l

0.19

221

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

158

1.97

3.14

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

230

1.80

3.12

1.8

1.5

—

(4062490)

180

1.90

3.10

1.8

1.4

—

(3024932) HLA-DR beta [Type]

2.81

3.08

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

315

0.38

3.07

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

313

0.38

3.03

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

546

1.50

3.02

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.36

2.98

1.3

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

377

4427

0.83

2.97

4.7

4.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

324

0.40

2.96

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.47

2.96

2.7

2.3

—

(3025130) Human papilloma virus identified in Specimen

240

0.37

2.92

1.4

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.72

2.92

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

5.40

2.87

1.4

0.2

0.8

ml/s/173m2

—

(1002224) Polysomnography panel

757

0.61

2.84

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1080

0.68

2.83

9.4

10.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

556

0.55

2.82

1.1

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

291

1.66

2.82

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

187

1.83

2.79

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

1790

18632

0.86

2.76

15.9

15.1

38.2

39.4

3.68

921

13164

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

178

1393

1.30

2.76

1.3

1.2

98.2

152.2

iu/ml

1.14

533

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

435

0.50

2.75

1.1

1.4

90.1

33.3

e6/l

0.29

335

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

138

1.97

2.75

1.3

1.2

—

(4094501)

550

0.56

2.73

1.0

1.1

—

(3026008) Bacteria identified in Urine by Culture

717

6450

1.16

2.71

3.3

3.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.60

2.70

2.5

1.4

14.4

8.6

ug/l

1.46

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

2.70

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

481

5471

0.85

2.61

4.0

3.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

822

0.65

2.57

1.4

1.3

31.6

29.6

iu/l

0.13

708

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

185

1.79

2.57

1.2

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

551

0.58

2.55

1.4

2.6

0.0

g/l

0.00

515

(3014148) Varicella zoster virus Ab [Titer] in Serum

216

1.72

2.52

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

241

1.67

2.44

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

226

1.69

2.43

1.4

51590.4

73619.2

e6/l

0.29

132

(3003694) ABO and Rh group [Type] in Blood

498

5618

0.86

2.42

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

273

1.62

2.41

1.0

1.1

8.4

2.4

u/ml

—

114

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

2.40

1.2

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

2.42

2.37

1.7

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

155

1.82

2.30

1.1

1.2

1.6

1.3

u/ml

0.08

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

558

0.60

2.28

1.4

2.5

0.0

g/l

0.00

516

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

127

1.90

2.26

1.0

1.1

—

(40758358) Immune stain study

5.56

2.21

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

198

0.40

2.16

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.69

2.15

2.9

5.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

227

1.64

2.14

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

562

1.40

2.14

1.3

168.1

216.2

miu/ml

0.70

264

(3000330) Specific gravity of Urine by Test strip

1078

0.72

2.14

5.2

3.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.91

2.07

2.2

2.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

599

0.65

2.00

1.7

2.5

0.0

g/l

1.42

554

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

606

6661

0.88

2.00

3.5

3.1

36.9

33.6

u/l

0.30

557

6316

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

262

2230

1.20

1.97

1.9

1.7

1.5

0.34

221

1936

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

619

0.66

1.95

1.6

1.8

—

(3012441) Differential panel - Pleural fluid

210

1.63

1.94

1.5

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.97

1.93

1.1

1.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

193

2313

0.82

1.91

6.4

7.4

11.4

12.3

kpa

2.12

178

2203

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

516

1.39

1.89

1.9

4.7

4.6

iu/l

0.02

184

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

156

0.38

1.89

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.65

1.86

1.0

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

194

2313

0.83

1.83

6.4

7.4

5.2

5.1

kpa

0.66

177

2200

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.17

1.82

1.4

4.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

270

1.53

1.82

1.2

4.6

4.5

u/ml

0.02

112

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.01

1.80

1.0

1.1

151.8

191.5

iu/ml

0.39

(40768806) Pleura Pathology biopsy report

215

1.59

1.79

1.6

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.76

1.79

1.4

1.1

—

(3003396) Base excess in Arterial blood by calculation

194

2304

0.83

1.76

6.4

7.4

1.0

1.1

mmol/l

0.18

159

1801

(3052851) Hemolysis interference index of Serum or Plasma

616

0.68

1.76

4.9

3.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.90

1.75

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1052

0.75

1.74

2.3

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.34

1.74

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

412

4601

0.88

1.72

4.1

4.4

20.3

21.6

1.09

242

2278

(3003740) Influenza virus B Ag [Presence] in Specimen

284

1.49

1.67

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

305

0.55

1.66

2.2

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

581

1.34

1.66

2.4

2.1

1297.7

3222.2

u/l

1.17

246

(3002523) Influenza virus A Ag [Presence] in Specimen

285

1.48

1.64

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

605

0.69

1.62

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

249

0.52

1.59

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

602

0.69

1.58

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

3.00

1.58

1.8

2.0

1.1

1.4

mg/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

235

0.51

1.57

1.6

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

122

1.73

1.54

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

153

1.64

1.53

1.4

2.1

6.1

6.8

mmol/l

1.25

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

597

0.70

1.52

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

350

1.41

1.50

1.2

254.9

258.4

u/ml

0.03

209

(3016750) Collection duration of Urine

128

0.39

1.49

2.6

2.1

543.4

499.1

min

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

116

1.73

1.48

1.6

1.5

0.9

2.1

u/field

—

(4306422)

268

1.46

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

378

3393

1.13

1.46

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

0.42

1.37

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

104

1.74

1.37

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

123

0.41

1.36

1.0

1.4

—

1.4

—

(3022621) pH of Urine by Test strip

165

1400

1.19

1.35

3.1

3.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

933

0.78

1.35

3.3

2.6

1.1

1.2

0.32

924

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.15

1.33

2.0

2.3

14.0

18.7

umol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

695

0.74

1.33

1.3

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

128

1.65

1.33

2.0

1.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

419

1.34

1.32

1.8

1.7

—

(40768441) Liver Pathology biopsy report

152

1.58

1.31

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

148

0.47

1.31

1.3

1.5

—

67.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.50

1.30

3.2

1.7

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.36

1.29

3.0

3.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

131

0.46

1.28

1.2

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

115

1.66

1.24

1.4

1.7

7.6

7.8

mmol/l

0.10

(3011648) Oxygen content in Venous blood

159

0.50

1.24

2.8

2.7

11.1

10.9

—

159

(3004716) Salmonella sp identified in Stool by Organism specific culture

1021

0.80

1.24

1.4

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.86

1.24

2.4

2.6

1134.3

623.8

e6/l

0.50

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

270

1.41

1.23

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

139

1.59

1.23

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.17

1.21

3.0

3.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

715

0.76

1.19

1.5

—

(1616796) Gas panel - Central venous blood

439

0.70

1.16

2.8

3.6

—

(3000285) Sodium [Moles/volume] in Blood

0.00

1.16

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.50

1.15

4.4

2.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

1.15

0.0

5.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

249

1.41

1.14

1.1

1.3

—

nmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

308

3408

0.89

1.14

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

156

0.51

1.13

1.1

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.34

1.12

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

1.63

1.12

1.1

—

(4281824)

245

0.61

1.11

1.7

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.78

1.10

1.1

1.8

61.3

183.6

umol/l

—

(3002619) Bacteria identified in Specimen by Culture

2.26

1.10

1.4

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

433

1.30

1.10

1.1

1.2

3.6

3.8

mmol/l

0.78

405

(3018677) aPTT in Platelet poor plasma by Coagulation assay

336

3053

1.12

1.09

2.5

2.0

28.4

29.8

5.49

319

2955

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

422

0.71

1.09

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

327

0.67

1.08

2.0

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

160

1386

1.16

1.07

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.76

1.06

1.2

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

410

1.30

1.05

2.6

1.7

1.0

0.9

nmol/l

0.37

335

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.28

1.03

1.4

2.6

—

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.84

1.02

1.2

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

416

0.72

1.02

2.3

2.5

15.7

16.1

0.24

203

(3042111) Morphology [Interpretation] in Bone marrow Narrative

358

0.70

1.02

1.3

1.5

—

(3000012) Reticulocyte production index

107

0.47

1.01

1.4

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

176

0.57

1.00

2.2

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

199

1.41

0.95

1.0

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

233

1.38

0.95

1.1

1.0

0.8

2.3

u/ml

1.45

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.15

0.91

1.0

1.1

—

(3016502) Oxygen saturation in Arterial blood

182

2046

0.88

0.91

6.5

7.8

94.0

95.6

1.92

175

1971

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

155

0.58

0.88

1.0

1.5

12.3

12.9

umol/l

—

147

(3000991) Gas panel - Venous blood

146

1657

0.87

0.85

8.8

8.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.94

0.84

3.2

3.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

113

0.53

0.83

2.7

2.1

—

(4268621)

180

1.39

0.82

1.9

2.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

164

0.61

0.80

1.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

122

1065

1.15

0.79

6.1

9.6

24.4

mmol/l

0.04

106

1001

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.79

0.0

1.3

—

(3008898) HLA-B27 [Presence]

675

1.19

0.79

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

147

0.61

0.79

1.1

—

185.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

474

0.78

1.7

2.4

239.9

103.8

ug/min

0.54

291

(3012565) Volume of 24 hour Urine

0.51

0.78

4.2

2.7

1505.0

1922.8

—

(3004451) EKG impression Narrative

0.50

0.77

1.0

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.77

0.0

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

303

0.72

0.77

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.76

0.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.64

0.75

1.3

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.71

0.70

1.0

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

214

1.31

0.66

1.1

1.8

3.7

u/ml

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.62

0.65

1.2

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

338

0.77

0.65

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

129

0.62

0.63

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

206

2244

0.91

0.63

1.6

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

478

1.20

0.63

3.6

3.5

23.7

25.4

mg/l

0.09

295

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

413

0.80

0.62

1.8

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

413

0.80

0.62

1.8

1.3

—

(3008295) Osmolality of Serum or Plasma

209

1.30

0.60

2.7

1.3

280.1

278.4

mosm/kgh2o

0.11

157

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.60

0.0

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.60

0.0

1.2

—

8.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

2.1

—

(3033658) Prothrombin time (PT) actual/Normal

496

5205

0.94

0.58

3.9

3.7

91.4

90.3

0.38

477

5060

(3033799) Differential panel - Peritoneal fluid

1.56

0.58

2.6

2.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

160

1755

0.91

0.58

5.8

7.1

1.4

mmol/l

0.23

153

1691

(4027681)

112

0.62

0.58

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.67

0.56

1.0

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

194

1.29

0.55

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

357

1.21

0.55

1.1

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.45

0.53

1.1

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.43

0.53

1.2

1.4

—

67.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.61

0.52

1.7

2.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

133

0.68

0.51

2.4

2.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.45

0.51

1.1

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

251

1.24

0.51

4.0

1.8

—

(3024928) Oxygen saturation in Venous blood

411

0.82

0.49

2.8

3.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.49

0.47

1.7

2.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

408

0.83

0.46

3.5

3.3

59.4

57.3

0.43

408

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

182

1691

1.08

0.46

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.40

0.45

1.4

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

210

1.24

0.45

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

302

1.19

0.44

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.37

0.44

1.3

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

131

0.69

0.43

1.4

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

101

1111

0.91

0.43

1.3

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

284

0.81

0.42

2.6

1.5

0.2

0.3

nmol/l

2.62

216

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.56

0.42

1.4

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

267

1.20

0.42

2.6

2.3

13.6

21.3

u/ml

0.18

254

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

272

0.81

0.41

1.7

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

3.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.41

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

391

0.84

0.41

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

305

1.18

0.40

1.1

2.7

4.7

u/ml

0.72

145

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.40

0.0

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

390

0.84

0.40

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

390

0.84

0.40

1.4

—

(3024263) Appearance of Synovial fluid

103

0.68

0.39

2.1

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

389

0.85

0.39

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.39

0.0

1.7

—

0.1

—

(3051611) Lipemic interference index of Serum or Plasma

213

0.80

0.36

6.1

3.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

278

0.83

0.36

1.3

1.2

8.5

3.7

u/ml

0.36

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.64

0.35

2.0

2.1

17.2

120.2

ug/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.62

0.35

7.6

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

826

0.91

0.35

2.0

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

426

0.87

0.34

2.1

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

222

0.81

0.34

3.8

3.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

557

1.12

0.34

2.3

2.4

3.4

3.7

g/l

0.61

525

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.33

0.33

1.5

2.6

—

(40757373) Influenza virus identified in Isolate

1.31

0.33

3.0

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.28

0.32

2.2

1.6

20.1

27.1

g/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

790

1.09

0.32

1.7

2.4

3.7

3.8

g/l

0.21

571

(44813793)

128

1.25

0.32

1.1

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

791

1.09

0.31

1.7

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

791

1.09

0.31

1.7

2.4

7.8

7.4

g/l

0.83

601

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.73

0.31

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.71

0.30

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

343

1.14

0.30

1.1

0.7

2.1

u/ml

1.48

137

(3035880) pH of Pleural fluid

111

1.26

0.30

1.1

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.25

0.29

1.4

1.3

81.6

111.7

nmol/l

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.23

0.29

1.0

1.2

—

12.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

259

0.85

0.28

1.1

1.3

7.2

7.3

mmol/l

0.07

187

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

150

0.80

0.27

1.3

1.5

1.0

g/l

0.15

150

(3027944) Amphetamines [Presence] in Urine

582

0.91

0.26

2.6

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1006

0.93

0.25

2.0

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

742

1.08

0.25

1.7

2.5

3.0

3.1

g/l

0.34

586

(1761482) Bacteria [#/volume] in Urine by Culture

531

1.09

0.25

5.9

4.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

179

1.17

0.25

1.4

2.2

0.8

1.9

u/field

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.20

0.25

1.1

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.18

0.24

1.0

1.1

1254.1

1782.5

miu/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

156

1638

0.95

0.24

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.71

0.24

1.0

2.3

163.7

146.3

—

(3045788) Cell count panel - Pleural fluid

201

0.84

0.23

1.3

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.32

0.23

1.0

1.1

21.3

44.3

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

275

1.13

0.23

1.1

0.3

2.1

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

368

0.90

0.22

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

304

0.89

0.21

1.1

1.3

—

(3025577) Chromium [Mass/volume] in Blood

126

1.19

0.21

2.3

2.0

0.8

2.1

ug/l

—

110

(3025315) Body weight

0.00

0.21

0.0

4.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

511

0.92

0.20

1.4

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.20

0.0

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.20

0.0

1.6

—

14.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

111

0.81

0.20

1.0

1.4

5.2

5.9

mmol/l

—

104

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.23

0.20

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

221

2287

0.96

0.20

2.8

2.6

11.1

8.3

umol/l

0.56

190

1978

(3033705) Calcium.ionized [Moles/volume] in Venous blood

250

1.12

0.19

2.9

2.4

—

(3051651) Icteric interference index of Serum or Plasma

118

1.19

0.19

6.7

4.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

203

1.13

0.19

1.0

0.1

0.4

u/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

1.19

0.18

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

217

0.87

0.18

1.7

1.5

—

(3027008) Opiates [Presence] in Urine

591

1.07

0.17

3.0

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.18

0.16

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

593

1.06

0.16

3.0

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

187

1.12

0.15

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.79

0.15

1.3

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.76

0.15

4.3

2.4

—

(3036489) Thrombin time

718

0.95

0.15

1.9

2.0

22.2

21.5

0.25

632

(3000764) Benzodiazepines [Presence] in Urine

586

1.06

0.14

3.0

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

304

1.09

0.14

1.5

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

450

1.07

0.14

3.5

3.1

8.2

8.1

kpa

0.27

406

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

624

0.94

0.14

1.4

2.4

36.9

37.7

g/l

0.42

542

(3008401) Mugwort IgE Ab [Units/volume] in Serum

295

1.09

0.14

1.1

0.3

1.5

u/ml

1.32

126

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

122

1.15

0.13

1.0

1.1

1.0

1.2

u/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

676

1.05

0.13

1.6

2.6

1.0

g/l

0.03

595

(40768800) Prostate Pathology biopsy report

376

0.93

0.13

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

478

0.94

0.12

1.6

1.4

—

(3011288) Drugs identified in Urine by Screen method

394

1.07

0.12

5.8

2.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

375

0.93

0.12

2.8

2.6

—

(3000492) Spirometry study

187

1916

0.97

0.11

1.6

1.5

—

(3002032) Base excess in Venous blood by calculation

179

1834

0.97

0.11

5.2

3.4

1.6

2.0

mmol/l

1.08

149

1476

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

115

0.87

0.10

1.0

1.2

67.9

77.7

u/l

—

(3021901) Oxygen saturation in Capillary blood

362

0.94

0.10

2.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.11

0.09

1.4

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

106

1.13

0.09

2.3

2.4

—

33.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.09

0.09

1.6

1.2

—

(3019060) Gas panel - Arterial blood

128

1314

0.97

0.09

4.3

4.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

448

1.05

0.09

1.7

2.2

128.7

129.4

g/l

0.05

322

(3023511) Choriogonadotropin [Units/volume] in Urine

319

0.94

0.09

1.4

1.2

—

(4198724)

1.11

0.09

1.8

1.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.03

0.08

2.5

1.8

34.2

27.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

588

1.04

0.08

2.7

2.1

96.1

91.0

1.18

546

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.03

0.07

3.7

2.2

106.6

144.3

nmol/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

733

0.97

0.07

1.6

2.5

9.8

10.2

g/l

0.36

629

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.81

0.07

1.0

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

451

1.04

0.07

3.1

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.02

0.07

6.4

3.4

—

(3017569) Oxygen content in Arterial blood

0.85

0.06

2.5

2.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

105

0.86

0.06

1.6

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

105

0.86

0.06

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

941

1.02

0.05

5.4

3.7

23.7

24.2

mmol/l

0.91

849

(3023419) Bacteria identified in Sputum by Culture

258

1.05

0.04

5.2

2.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

292

0.96

0.04

6.7

5.3

374.4

368.9

umol/l

0.06

253

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.07

0.04

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.07

0.04

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.07

0.04

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

546

1.03

0.04

3.3

1.6

—

(3012544) pH of Venous blood

192

1900

1.01

0.04

5.0

3.4

—

7.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

117

1182

0.99

0.02

2.4

3.6

85.2

62.6

u/ml

0.28

111

1143

(3006653) Thiamine [Moles/volume] in Blood

103

1.07

0.02

1.3

1.2

137.2

132.9

nmol/l

0.13

103

(3021447) Carbon dioxide [Partial pressure] in Venous blood

183

1840

0.99

0.01

5.1

3.4

5.9

5.8

kpa

0.16

174

1788

(44790049)

224

1.03

0.00

1.8

1.4

—

(44806118)

224

1.03

0.00

1.8

1.4

—

(44790047)

224

1.03

0.00

1.8

1.4

—

(44790048)

224

1.03

0.00

1.8

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

336

0.98

0.00

1.1

28.3

59.9

iu/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

125

0.96

0.00

3.8

6.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

265

1.02

0.00

1.1

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

299

1.00

0.00

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

150

1495

1.00

0.00

5.0

3.0

5.4

4.5

kpa

2.90

142

1446

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

106

1.04

0.00

24.2

13.5

812.7

863.3

nmol/l

0.13

100

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

116

1.03

0.00

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

138

1.01

0.00

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

138

1.01

0.00

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

138

1.01

0.00

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

335

3347

1.00

0.00

3.6

3.1

0.7

0.8

ug/l

0.49

238

2249

(3044941) Cell count panel - Synovial fluid

313

0.99

0.00

1.5

—

(3047189) Immunofixation for 24 hour Urine

1.03

0.00

2.6

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.86

0.00

2.0

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.86

0.00

2.0

2.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

13.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.90

0.00

1.2

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.02

0.00

3.2

1.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

259.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.94

0.00

2.1

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.2

—

4.8

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

389.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

13.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.94

0.00

2.0

—

(3015183) Erythrocyte sedimentation rate

0.94

0.00

1.0

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

4.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SKINSUBCUTISNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_SKINSUBCUTISNAS	1.368 [1.23, 1.52]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.191

During the follow-up period (1.1.1998 — 31.12.2019), 1166 out of 6189 females with L12_SKINSUBCUTISNAS died.

Males

Parameter	HR [95% CI]	p-value
L12_SKINSUBCUTISNAS	1.462 [1.29, 1.65]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 1088 out of 4258 males with L12_SKINSUBCUTISNAS died.

Mortality risk

Mortality risk for people of age

years, who have L12_SKINSUBCUTISNAS.

N-year risk	Females	Males
1	0.116%	0.266%
5	0.766%	1.559%
10	1.775%	4.387%
15	3.456%	8.53%
20	6.376%	14.554%

Relationships between endpoints

↥

Index endpoint: L12_SKINSUBCUTISNAS – Other and unspecified disorders of skin and subcutaneous tissue

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified disorders of skin and subcutaneous tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints